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CHAPTER I 
 
BACKGROUND 
 
Introduction 
Virus attachment and internalization into host cells are essential steps in the viral 
infectious cycle that enable viruses to engage target cells and initiate infection in the host.  
A virus must bind to cells and breach the host cell membrane to deliver the genetic 
payload to the site of viral replication.  Hence, virus-receptor interactions serve as 
important determinants of viral tropism and pathogenesis as they are requisite for all 
subsequent steps in the viral life cycle.  To ensure proper entry into cells, viruses have 
adapted complex and elegant strategies to recognize their respective cellular targets.   
Mammalian reoviruses are nonenveloped double-stranded (ds) RNA viruses that 
infect a broad range of hosts in nature (248).  Reoviruses are pathogenic in mice, 
infecting most organs including the central nervous system (CNS), heart, and liver (248).  
Reoviruses first attach to the cell surface by binding to carbohydrate (9, 52), which is α-
linked sialic acid for serotype 3 strains (14, 52, 189, 196).  All reovirus strains bind to 
proteinaceous receptor junctional adhesion molecule-A (JAM-A) to mediate high-affinity 
attachment (15, 43, 204).    
Upon commencement of my dissertation research, it was not known whether 
JAM-A mediates reovirus internalization following attachment to host cells.  Thus, the 
receptor responsible for reovirus cell entry and mechanisms responsible for this process 
were undetermined.  Reovirus is reported to enter cells by receptor-mediated endocytosis 
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(32, 33, 239), which is most likely clathrin-dependent (85, 215).  However, it was not 
known whether clathrin-dependent uptake serves as a functional route of reovirus entry 
resulting in productive infection.  Reovirus requires disassembly steps in the endocytic 
compartment (72, 239), but the exact fate of reovirus virions in the endocytic pathway 
was unknown.   
In my dissertation research, I sought to determine and characterize mechanisms of 
reovirus internalization.  In Chapter II, I report that β1 integrin mediates reovirus 
internalization.  In Chapter III, I show that tyrosine residues in the β1 integrin 
cytoplasmic domain are required for functional reovirus entry.  This research provides a 
deeper understanding of how reovirus enters into host cells and is delivered to the 
endocytic pathway.  Furthermore, these findings contribute to an understanding of how a 
nonenveloped virus utilizes cellular machinery to mediate the functions of attachment 
and cell entry and elucidates the physiologic function of β1 integrin in endocytosis.    
 
Virus Attachment and Entry 
Initial engagement of a host cell by a virus is mediated by an attachment protein 
on the outer shell of the virus and receptors on the surface of target cells.  Interactions 
between the attachment protein and viral receptors serve to tether the virus to the cell 
surface.  Viral receptors include cell-surface carbohydrates, which serve as a low-affinity, 
high-avidity attachment moiety, and in many cases, proteinaceous receptors, which 
mediate high-affinity interactions with viral proteins (161).  Some viruses utilize one 
receptor to mediate both attachment and internalization.  For example, echovirus, a 
nonenveloped virus, binds to α2β1 integrin, which mediates cell attachment (24) and 
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caveloae-dependent endocytic uptake (159).  However, many viruses use independent 
receptors for attachment and entry.   
There are two main types of viruses, enveloped and nonenveloped, which use 
distinctly different mechanisms to enter host cells.  Entry of most enveloped viruses is 
mediated by fusion of the viral envelope with cell membranes.  Nonenveloped virus entry 
is facilitated by receptor engagement and internalization through one of many endocytic 
pathways.  In the case of human immunodeficiency virus type 1 (HIV-1), which is 
enveloped, the viral attachment glycoprotein, gp120 binds to CD4 on the surface of T 
cells or macrophages (67, 138).  After initial binding, gp120 interacts with chemokine 
receptors (75), which induces a conformational change in gp120.  This conformational 
change exposes a fusion peptide in gp41 that mediates fusion of the viral envelope and 
plasma membrane (92).  In the case of the DNA tumor virus simian virus 40 (SV40), 
which is nonenveloped, binding to cell-surface major histocompatibility complex class I 
(36) triggers entry by caveolae-dependent endocytosis for delivery to the endoplasmic 
reticulum (ER) and finally to the nucleus (131).   
There are a variety of mechanisms by which nonenveloped viruses can internalize 
into target cells.  Most nonenveloped viruses use receptor-mediated endocytosis, a 
process by which cells internalize cargo into vesicles formed at the plasma membrane 
(161).  Endocytic pathways employed by viruses include clathrin-mediated endocytosis 
(127, 194) and non-clathrin-dependent pathways such as caveolae-mediated endocytosis 
(159, 201), macropinocytosis (164), and non-clathrin/non-caveolae-mediated endocytosis 
(161, 219).  The most common type of receptor-mediated endocytosis employed by 
viruses is clathrin-dependent endocytosis (161).  Clathrin consists of heavy and light 
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chains that are capable of self-assembling into a lattice to form a clathrin cage (173).  In 
clathrin-mediated endocytosis, clathrin is recruited to the plasma membrane by adaptor 
proteins, which serve many cellular trafficking functions.  Some adaptor proteins recruit 
clathrin to the cell surface and link clathrin, the plasma membrane, and the receptor that 
has induced the endocytic signal.  For example, the adaptor protein-2 (AP-2) complex 
consists of four subunits: α, β2, μ2, and σ (82).  The μ2 subunit directly engages specific 
sorting signal motifs in the cytoplasmic domain of receptors to mediate clathrin-
dependent endocytosis and cargo sorting (55, 116, 182, 186).  The β2 subunit binds to 
clathrin through a specific sequence known as a clathrin-box motif (187); β2 also 
functions in cargo selection (82).  The α subunit binds to the plasma membrane (96).  
The AP-2 complex leads to clathrin accumulation at the plasma membrane, where 
clathrin self-assembles to form a clathrin-coated pit (CCP) (173).  Cargo is internalized 
into the CCP, and the nascent vesicle is excised from the plasma membrane by the 
activity of dynamin, a GTPase (69).  The CCP then forms a clathrin-coated vesicle 
(CCV) that transports cargo to the proper endocytic compartment (173).  Many 
nonenveloped viruses are targeted to early or late endosomes to undergo pH-dependent 
conformational changes to initiate viral disassembly or membrane fusion (161).  
 
Reovirus Structure and Genome Organization 
 Mammalian reoviruses are in the orthoreovirus genus of the Reoviridae family.  
Reoviruses are nonenveloped, icosahedral viruses (76) that contain a segmented double-
stranded (ds) RNA genome (178) (Fig. 1).  Reovirus genes are arranged into three classes  
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Fig. 1.  Schematic Diagram of Reovirus Virion.  Reoviruses form icosahedral 
virions with an outer capsid and an inner core. The outer capsid proteins σ1, σ3, μ1, 
and λ2 are indicated.  The inner core encapsidates the viral genome, which is 
composed of 10 dsRNA segments.   
σ1
Outer capsid
Core
λ2
L1
L2
L3
M1
M2
M3
S1
S2
S3
S4
(σ3 and μ1)
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based on size: three large (L1, L2, L3), three medium (M1, M2, M3), and four small (S1, 
S2, S3, S4) (178).  Each gene segment encodes a single protein, with the exception of S1, 
which encodes two proteins (87, 125).  Reovirus proteins are named with Greek letters λ, 
µ, and σ relating to the size class of the encoding gene.  However, the gene segments and 
protein names do not always correspond.  Reovirus encodes eight structural proteins (λ1, 
λ2, λ3, µ1, µ2, σ1, σ2, and σ3), which form the viral outer capsid and core (178), and 
three nonstructural proteins (µNS, σNS, σ1s), which are expressed in reovirus-infected 
cells (20, 21, 39, 45).   
Reovirus virions form two concentric protein shells, the outer capsid and core 
(Fig. 1).  The outer capsid serves to stabilize the virion in the environment, and the core 
contains the viral genome and is responsible for viral transcription and genome 
replication.  The outer capsid consists of structural proteins σ1, σ3, µ1, and λ2 (76, 145).  
σ1 is the viral attachment protein and mediates binding to target cells (93, 145, 260).  σ3 
is a major component of the viral outer capsid and serves to protect the virion in the 
environment and regulate viral disassembly in cellular endosomes (104, 149).  During 
viral disassembly, σ3 is removed from the virion particle and µ1 is exposed, which leads 
to virus escape from the endosomal compartment (46, 180).  λ2 is a pentameric protein at 
the virion fivefold axes and serves as the structural foundation for σ1 (76).  The 
aminoterminal domain of λ2 functions as a guanylyltransferase, which mediates the 
enzymatic activity of capping the 5’ end of viral plus-strand transcripts (60, 155).   
The structural proteins λ1, λ2, λ3, μ2, and σ2 form the reovirus core.  λ1 is the 
main structural component of the core.  σ2 assembles on to the λ1 shell and makes 
contacts with both λ1 and λ2 (208).  λ2 forms turrets at the icosahedral vertices of the 
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core (76).  λ3 is the catalytic subunit of the viral RNA-dependent RNA polymerase (234).  
μ2 is thought to interact with λ1, λ2, and λ3 and is hypothesized to be involved in RNA 
polymerase activity (178).  Nonstructural proteins σNS and μNS induce the formation of 
viral inclusions in the perinuclear space that serve as sties of viral replication (20, 21, 38, 
39).  Both σ1 and σ1s are translated from the viral S1 gene (87, 125).  σ1s is not required 
for viral replication (210), yet it has been linked to apoptosis and cell-cycle arrest (202) 
by a mechanism that remains unclear.   
 
Reovirus Pathogenesis 
 Reoviruses were first isolated in the 1950s by Albert Sabin (216).  The original 
isolates were collected from children who presented with diarrhea.  The term reovirus 
(respiratory enteric orphan virus) was coined based on the absence of disease in 
association with a virus isolated from the respiratory and enteric tracts of humans (216).  
Reovirus is spread from host to host by fecal-oral transmission.  Generally, most 
individuals encounter the virus by five years of age and are asymptomatic (240, 248).   
 While reovirus is termed an orphan virus, reovirus infection can lead to disease in 
humans.  Experimental reovirus infections in seronegative adult male prisoners produced 
malaise, headache, nasal congestion, and cough (212).  Reovirus isolated from children 
has been associated with gastrointestinal symptoms including diarrhea (213) and 
respiratory symptoms (121) including runny nose, sore throat, and earache (213).  Some 
studies have suggested that reovirus contributes to biliary artresia, a progressive 
inflammatory disease of the liver, in newborn children (251).  In support of this 
association, reovirus produces biliary disease in mice (16, 267).  Additionally, reovirus 
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has been isolated from children with CNS disease including encephalitis (129, 137) and 
meningitis (249).  Therefore, while reovirus is not considered a significant human 
pathogen, reovirus infection can cause disease in humans, especially in neonates.   
 
Reovirus Mouse Model 
Reovirus is highly virulent in neonatal mice (242), which are the preferred 
experimental system for studies of reovirus pathogenesis (257).  Mice can be infected 
with reovirus by peroral (PO), intracranial (IC), intraperitoneal (IP), or footpad 
inoculation.  After PO inoculation of mice, reovirus attaches to and enters intestinal 
microfold (M) cells (269) and subsequently undergoes primary replication in lymphoid 
cells of the Peyer’s patches (PPs) (17, 214).  After primary replication in the small 
intestine, reovirus spreads and infects distant organs including the kidney (192), liver 
(191), heart (110), and brain (126, 158, 200).  Reoviruses can cause a variety of disease 
phenotypes in mice including myocarditis (110, 227) and biliary inflammation (16, 190).  
Reoviruses are most noted for the capacity to cause disease in the CNS (260) in which 
viral infection can lead to hydrocephalus (259) or a lethal encephalitis (242, 259), 
depending on the strain.   
Reovirus serotypes differ in host-cell tropism and disease outcomes.  There are 
three reovirus serotypes (T1, T2, and T3).  For each serotype there exists a commonly 
used laboratory prototype strain, type 1 Lang (T1L), type 2 Jones (T2J), and type 3 
Dearing (T3D) (248).  After PO inoculation of neonatal mice, T1 reovirus spreads 
hematogenously (132), infects ependymal cells in the CNS (243, 250), and causes 
hydrocephalus (259).  T3 reovirus spreads neurally through the vagus nerve (171), infects 
8
neurons (171, 248, 260), and causes lethal encephalitis (242, 259).  The striking 
differences in viral tropism observed between T1 and T3 reovirus strains in the CNS 
segregate with the σ1-encoding S1 gene segment (243, 260), suggesting an important 
function for receptor engagement in tropism determination (250, 260).   
The σ1 protein engages two receptors on the cell surface, carbohydrate and JAM-
A.  T3 reovirus strains bind to α-linked sialic acid (14, 52, 189, 196), while T1 strains 
bind to an unidentified carbohydrate.  Differences in reovirus tropism by T1 and T3 
strains cannot be explained by differential utilization of the only known σ1 head receptor, 
JAM-A.  Cell culture and biochemical studies show that JAM-A is a serotype-
independent receptor (43).  Moreover, JAM-A-null mice are susceptible to reovirus 
infection (Antar, A.A.R. and Dermody, T.S., unpublished results).  In contrast, 
carbohydrate binding serves an important function in reovirus pathogenesis and disease 
outcome.  Sialic-acid binding strain T3SA+ and non-sialic acid binding strain T3SA-, 
which differ only by a single point mutation that confers binding to sialic acid (14), 
produce equivalent viral titers in the murine intestine after PO inoculation (16).  
However, T3SA+ spreads more rapidly from the intestine to sites of secondary infection 
and produces higher viral titers in several organs including the liver and brain (16).  
Furthermore, mice infected with T3SA+ develop inflammation of intrahepatic bile ducts 
and steatorrhea, similar to the findings associated with biliary atresia in humans (16).  
These observations indicate that virus coreceptor utilization can influence viral tropism 
and disease outcome.  
The σ1 protein is not the sole viral determinant of reovirus disease outcome.  The 
reovirus λ2-encoding L2 gene segment is linked to viral shedding from the intestine and 
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spread to littermates in pathogenesis studies in mice (134).  The L2 gene also modulates 
reovirus infection in the intestine after PO inoculation (28).  Therefore, other components 
of the viral outer capsid influence reovirus tissue tropism and disease outcome. 
 
Reovirus Attachment and Entry 
Reovirus attachment protein σ1 is a long filamentous protein that extends away 
from the virion surface and initiates contact with target cells (93).  σ1 has a globular head 
and a long fibrous tail.  The structure of the C-terminal half of σ1 reveals a homotrimer 
(53) that bears striking homology to the adenovirus attachment protein, fiber (255) (Fig. 
2) .  The head domain folds into a compact eight-stranded β-barrel motif (53) and is the 
portion of the protein that binds to JAM-A (223).  σ1 contains a second receptor-binding 
domain below the head in the tail region of the molecule, which is known to bind 
carbohydrate (51, 52).  T3 reovirus strains bind sialic acid (14, 52, 189, 196), while T1 
strains bind to an unidentified carbohydrate.  Carbohydrate binding is thought to tether 
the virus to the cell surface prior to high-affinity binding to JAM-A in an adhesion-
strengthening manner (16).   
JAM-A is an immunoglobulin (Ig) superfamily member, with two Ig-like 
domains, D1 and D2, a short transmembrane region, and a short cytoplasmic tail (162).  
The cytoplasmic region of JAM-A contains multiple phosphoacceptor sites and a PDZ 
(Post-synaptic density-95/Discs-large/Zonula occludens-1)-binding motif, which could 
serve as a binding site for PDZ-containing proteins, such as zonula occludens-1 (ZO-1) 
(79) and multiple-PDZ-domain-protein (MUPP1) (81).  JAM-A localizes to tight 
junctions in polarized epithelial cells (162) and homodimerizes with other JAM-A  
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 Fig. 2.  Structural Similarities Between the Reovirus σ1 and Adenovirus Fiber.  
Shown are ribbon tracings of the crystallized portions of reovirus σ1 (left) and 
adenovirus fiber (right).  Both proteins are timers shown as three monomers in red, 
orange, and blue.  σ1 and fiber have large globular head domains formed by an eight-
stranded β-barrel and long fibrous tails containing a triple β-spiral motif.  These 
proteins are homologous in structure and function.  The σ1 structure image was 
reproduced from The EMBO Journal, 2002, 21:1-11.  Copyright © 2002 Nature 
Publishing Group.  The fiber structure image was reproduced from Nature, 1999, 
401:935-938.  Copyright © 1999 Nature Publishing Group.   
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molecules either on the same or opposing cells (18).  JAM-A serves as a receptor for 
prototype and field-isolate strains of all three reovirus serotypes (43).  σ1 binds to the D1 
domain of JAM-A with a KD of ~10-8M (15, 223).   
The crystal structure of JAM-A reveals a dimer formed by interactions of the 
GFCC’ faces of opposing D1 domains (136, 204).  JAM-A bears striking homology to 
the coxsackievirus and adenovirus receptor (CAR) (27, 204) (Fig. 3).  Reovirus σ1 
engages JAM-A monomers using sequences in β-strands on C and C’ of the GFCC’ face 
of the JAM-A D1 domain, which mediate dimer interactions (Guglielmi, K.M. and 
Dermody, T.S., submitted).  Since σ1 engages JAM-A using contacts that stabilize JAM-
A dimers, it is possible that σ1 disrupts the dimer to bind monomeric forms of the 
receptor (Guglielmi, K.M. and Dermody, T.S, submitted).   
 Reovirus enters cells by receptor-mediated endocytosis (32, 33, 239), which is 
thought to be dependent on clathrin (85, 215) (Fig. 4).  Reovirus is delivered to an 
endocytic compartment where steps in viral disassembly occur to form infectious 
subvirion particles (ISVPs) (33, 49, 228, 239).  During this process, σ3 is removed and 
μ1 is cleaved to form two particle-associated fragments, δ and φ (176, 239).  The σ1 
protein undergoes a conformational change and extends away from the surface of the 
virion (93).  ISVPs also can be generated in vitro by digesting virions with protease (11).  
ISVPs generated in vitro bind to cell-surface receptors (15) but directly penetrate the 
plasma membrane, thus bypassing a requirement for disassembly in the endocytic 
compartment (11, 115, 239).  The ISVP is subject to further conformational change to 
yield the ISVP*, in which the μ1 protein has undergone a conformational change to μ1* 
(46, 47).  This conformational change exposes hydrophobic residues in the μ1 cleavage  
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Fig. 3.  Structural Similarities Between the Crystal Structure of JAM-A and 
CAR.  Shown are the ribbon tracings of the crystallized D1 domains of reovirus 
receptor JAM-A (bottom) and adenovirus receptor CAR (top).  Both proteins are 
dimers shown as two monomers in blue and gold.  JAM-A and CAR are Ig-
superfamily members, and both localize to tight junctions of polarized epithelial cells.  
The JAM-A structure image was reproduced from PNAS, 2003, 100: 5366-5371.  
Copyright, © 1993-2005, The National Academy of Sciences of the United States of 
America.  The CAR structure image was reprinted from Structure, 8, van Raaij, M.J., 
Chouin, E., van der Zandt, H., Bergelson, J.M., Cusack, S. Dimeric Structure of the 
Coxsackievirus and Adenovirus Receptor D1 Domain at 1.7 A Resolution.,1147-
1155, Copyright © 2000, with permission from Elsevier.    
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Fig. 4.  Reovirus Entry and Disassembly.  Reovirus attachment to cells is mediated 
via σ1 binding to carbohydrate, sialic acid for type 3 strains, and JAM-A for all 
reovirus serotypes.  After binding to receptors, the virus enters cells by receptor-
mediated endocytosis, which is thought to be clathrin-dependent.  Virions are 
delivered to an endocytic compartment where they undergo disassembly to an 
infectious subvirion particle (ISVP), in which the σ3 protein is removed and the μ1 
protein is cleaved to particle-associated fragments, δ and φ.  The ISVP undergoes 
further conformational rearrangement to form an ISVP*, in which σ1 is lost and μ1 
undergoes a conformational change to μ1*, which can penetrate the endosomal 
membrane and release the transcriptionally active core into the cytoplasm.   
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fragments and renders the ISVP* capable of penetrating endosomal membranes (2, 46, 
47).  During the ISVP-to-ISVP* transition, conformational changes also occur in λ2 (76) 
(Fig. 5), leading to loss of σ1 from the λ2 turrets.  ISVP*s penetrate the endosomal 
membrane and release the transcriptionally active core into the cytoplasm (180).  
 Reovirus disassembly requires an acidic compartment, as treatment of cells with 
ammonium chloride, a weak base, blocks infection by reovirus virions but not by ISVPs 
(72, 239).  Sensitivity to ammonium chloride is linked to the σ3-encoding S4 gene 
segment, and specific residues in σ3 regulate acid-dependent reovirus disassembly (58, 
78, 268).  Reovirus disassembly is catalyzed by the activity of cathepsins, a class of 
endosomal proteases (11, 77).  In fibroblasts, cathepsins B and L are capable of 
mediating σ3 removal and μ1 cleavage.  Cathepsin L is more efficient, but cathepsin B 
can catalyze reovirus disassembly in the absence of cathepsin L (77).  Thus, reovirus 
disassembly is a tightly regulated process during which viral and cellular components act 
to remove the viral outer capsid.    
 
Reovirus Replication and Assembly 
Following attachment, internalization, and disassembly, the reovirus core is 
released into the cytoplasm.  The core is transcriptionally active (147, 226, 229) and 
synthesizes 10 capped viral mRNAs (94, 95), which are released from the core through 
the five-fold channels formed by the λ2 pentamer (13, 76, 154) (Fig. 6).  Viral transcripts 
serve as templates for synthesis of viral proteins (279) or are packaged into nascent 
particles and serve as templates for minus-strand synthesis to generate the dsRNA 
segments (8, 224, 277, 278).  Additional transcripts are synthesized by newly formed    
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Fig. 5.  Conformational Changes in the Reovirus Virion, ISVP, and Core.  Cyro-
electron micrograph (EM) reconstructions demonstrate the transition of reovirus from 
a virion to core.  The reovirus virion shows icosahedral symmetry with λ2 shown at 
the five-fold axes of symmetry.  The outer capsid proteins σ3 and μ1 project from the 
surface of the virion. σ1 is not visualized by cryo-EM.  In the ISVP, σ3 has been 
removed.  In the core particle, outer capsid proteins have been completely removed, 
and λ2 has undergone conformational changes that open the turret.  Reproduced from 
Journal of cell Biology, 1993, 122: 1023-1041.  Copyright 1993 Rockefeller 
University Press.    
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Fig. 6.  Reovirus Replication and Assembly.  Following attachment, endocytosis, 
and disassembly in endosomes, the transcriptionally active reovirus core is delivered 
into the cytoplasm.  Viral transcripts are released from the viral core and serve as 
template for translation of viral proteins or are packaged into particles and serves as 
template for minus-stand synthesis of the dsRNA genome.  Transcripts released from 
newly formed cores serve as template for secondary rounds of transcription and 
translation.  Structural proteins encapsidate the core particle containing the viral 
genome, and virions are released from cells.     
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particles for secondary rounds of protein synthesis (230, 275, 278).  Reovirus genome 
packaging is a highly regulated process that ensures that the 10 unique gene segments are 
packaged into cores (76, 109), but the mechanism by which this occurs is unknown.  The 
transcriptionally active core particles containing viral genomic dsRNA are encapsidated 
with outer-capsid proteins to form mature viral progeny (48, 62, 111, 270), which then 
egress from the cell.  
 
Integrins 
Integrins are cell-surface adhesion molecules that have broad physiologic 
expression in invertebrates and vertebrates.  They mediate adhesion to the extracellular 
matrix (ECM) and link the ECM to the cytoskeleton (117).  Integrins function in many 
cellular processes including cell-cell contacts, intracellular signaling, endocytosis, and 
cell spreading (117, 153).  Integrins play a major role in normal physiology and disease.  
Integrins function in development (10, 237, 272, 273), immunity (84, 238), cancer 
metastases (5, 34), and tissue homeostasis (117).  Integrins also serve as receptors for 
many pathogens including viruses and bacteria (117, 120).      
  There are 18 α and 8 β integrin subunits that assemble to form 24 types of αβ 
heterodimer pairs (153).  Integrin αβ pairs differ in ligand recognition, links to 
cytoplasmic proteins, and signaling properties and, thus, these molecules perform largely 
non-redundant functions (117).  The α and β subunits are type I transmembrane 
glycoproteins with globular extracellular domains, transmembrane regions, and short 
cytoplasmic domains less than 50 amino acids (153, 241) (Fig. 7).  The α subunits are  
18
βα
Ligand
I I like
Fig. 7.  Schematic Diagram of Integrins.  Integrins are cell adhesion receptors 
comprised of an α and β subunit.  Each subunit is comprised of an extracellular 
domain, a transmembrane region, and a short cytoplasmic tail.  Some α subunits 
contain an I (inserted) domain, which serves as a ligand-binding domain.  β subunits 
contain an I-like domain, which can also serve as a ligand-binding domain.    
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approximately 120-180 kilo Daltons (kDa), while the β subunits are approximately 90-
110 kDa (241).  The amino termini of the α and β subunits form globular heads that 
associate on the cell surface.  Divalent cations mediate association of some α and β 
subunits and are required for ligand specificity and binding.  Half of the known α 
integrins have an extra, “inserted” (I) domain of approximately 200 amino acids, which 
contains a unique metal ion coordination site known as a metal-ion-dependent adhesion 
site (MIDAS) that binds to negatively charged residues of ligands (153, 241).  The I 
domain is the ligand-binding domain for integrins that incorporate this feature (70, 74, 
133).  The integrin β subunit contains a domain that is similar to the α integrin I domain, 
which is approximately 240 amino acids and known as an I-like domain (241).  The β 
integrin I-like domain contains residues that resemble the MIDAS sequence in the α 
subunit (143).  The β integrin I-like domain can function as a ligand-binding domain for 
integrins that lack an α I domain (205, 246) and also cooperates in ligand binding in 
integrin heterodimers that engage ligands using an α I domain (241).  Ligands also can 
bind integrins via a pocket formed by the α and β subunits (117).   
Many integrins recognize ligands that contain a short peptide motif that 
incorporates an acidic amino acid.  The most commonly recognized integrin-binding 
motif is the Arg-Gly-Asp (RGD) sequence in ECM proteins fibronectin and vitronectin 
(117).  α4, α5, α8, αIIb, and αv integrins engage ECM ligands using an RGD-dependent 
interaction (241).  Other integrin-binding motifs have been reported including Asp/Lys-
Gly-Glu (117).  α2β1 integrin binds to a DGEA sequence in collagen I (233).  Although 
there are many examples of integrin binding mediated by specific sequence motifs, this is  
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not the only mechanism of integrin adhesion.  In fact, some RGD-binding integrins can 
engage ligands in an RGD-independent fashion (86, 117).   
Integrins stimulate bidirectional signaling events upon ligand binding that 
regulate cell function, proliferation, and survival (117).  Following integrin-ligand 
engagement and integrin clustering, the integrin cytoplasmic domains recruit signaling 
proteins and induce assembly and remodeling of actin filaments forming focal adhesions 
(FA) (35).  The β integrin subunit recruits several cytoplasmic kinases including focal 
adhesion kinase (FAK) (148), integrin-linked kinase (ILK) (107), and Src-family kinases 
(139).  For example, many β integrin cytoplasmic domains activate the FAK signaling 
pathway (195).  FAK binds either directly to the β integrin cytoplasmic domain (148) or 
indirectly via adaptor proteins, such as talin (42) or paxillin (222).  For example, β1 
integrin clustering leads to autophosphorylation of FAK through tyrosine residues in the 
Asn-Pro-any residue-Tyr (NPXY) motifs in the cytoplasmic domain (195).  
Autophosphorylation of FAK creates a binding site for the src homology 2 (SH2) domain 
of Src kinase (221), which can phosphorylate cytoplasmic proteins including paxillin 
(22).  
Integrin-linked signaling proteins bind to the actin cytoskeleton directly or via 
actin-binding proteins that regulate actin cytoskeleton formation and remodeling (35).  
For example, talin is capable of binding directly to β integrin cytoplasmic domains (271) 
and actin (113).  Biochemical linkage of talin and actin is important for cell adhesion, 
spreading, and formation of FAs and stress fibers (203).  Talin also links other 
cytoplasmic proteins to the actin cytoskeleton.  For example, the binding of 
phosphatidylinosital (4,5)-bisphosphate (PIP2) to the cytoskeletal protein vinculin reveals 
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a talin-binding site, and talin binding to vinculin and leads to association with actin (100).  
PIP2 and vinculin bind to the actin-related protein (Arp) 2/3 complex, which leads to 
actin polymerization and filament branching, thus mediating movement of the plasma 
membrane (71).   
 
Integrins and Pathogens 
 Given the ubiquitous nature of integrin expression, it is not surprising that a 
number of viruses and bacteria utilize integrins as receptors to facilitate attachment or 
entry into target cells  (120, 244).  Integrins serve as receptors for enveloped viruses that 
are internalized into target cells by fusion mechanisms.  West Nile virus (WNV), an 
enveloped ssRNA virus of the Flaviviridae family uses αvβ3 as a receptor (57).  WNV is 
a mosquito-borne pathogen that causes West Nile fever, which is associated with 
encephalitis and death in the elderly (105).  The WNV envelope protein engages αvβ3 in 
an RGD-independent fashion (144), leading to activation of FAK and viral internalization 
(57).  Human cytomegalovirus (HCMV), an enveloped dsDNA virus of the 
Herpesviridae family, utilizes α2β1, α6β1, and αvβ3 integrins to mediate viral entry via 
fusion and signal transduction (89).  The HCMV envelope glycoprotein B binds to 
integrins using a conserved integrin-binding disintegrin-like domain, RX5-7DLXXF/L 
(88, 89).  HCMV engagement of β1 integrins leads to phosphorylation of β1 integrin on 
threonine residues 788 and 789 and phosphorylation of FAK to mediate HCMV entry 
(89).   
Integrins are utilized by a number of nonenveloped viruses to mediate 
endocytosis.  Rotavirus, a member of the Reoviridae family that causes infantile diarrhea 
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(193), engages a variety of integrins for attachment and cell entry.  Rotavirus strains 
RRV, SA11, and Wa bind to the I domain of α2β1 integrin via a DGE integrin-binding 
motif in the VP4 spike protein to effect viral attachment (102).  Interactions of rotavirus 
outer-capsid protein VP7 with integrins αxβ2 and αvβ3 can mediate viral entry (102, 
274).  Integrin α4β1 also can serve as a receptor for rotavirus strain SA11, which 
contains α4β1 integrin-binding sequences Leu - Asp - Val in VP7 and Ile - Asp - Ala in 
VP4 (114).  The entry pathway of rotavirus is not well understood, but it is thought that 
rotavirus enters cells by receptor-mediated endocytosis that requires dynamin and 
cholesterol (219).  Foot-and-mouth disease virus (FMDV), a ssRNA virus of the 
Picornaviridae family that causes disease in animals including livestock, uses a number 
of αv integrins for attachment and entry.  αvβ1 (123), αvβ3 (25), αvβ6 (124), and αvβ8 
(122) all serve as receptors for FMDV.  The viral capsid protein, VP1, contains an RGD 
motif on a surface exposed loop, which is thought to bind αv integrins (123).  FMDV is 
internalized into cells by clathrin-dependent endocytosis and requires acidification in 
endosomes (26).  Confocal microscopy experiments demonstrate FMDV delivery to early 
and recycling endosomes along with αvβ6 integrin, suggesting that αvβ6 is required for 
both viral attachment and delivery of the virus to the endocytic pathway (26).    
Integrins also serve as receptors for both Gram-positive and Gram-negative 
bacteria.  Staphylococcus aureus is a Gram-positive bacterium that most commonly 
causes dermal infections, abscesses, pneumonia, and bone and joint infections (152).  S. 
aureus strains express extracellular matrix proteins in the cell wall including fibronectin-
binding proteins A and B, which mediate attachment to fibronectin.  As S. aureus 
interacts with fibronectin in an RGD-independent fashion, the fibronectin receptor α5β1 
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expressed on eukaryotic cells is still capable of interacting with fibronectin that is bound 
by S. aureus (1).  Thus, S. aureus acts as a link between fibronectin and host cell α5β1, 
which leads to internalization of the organism (1).  β1 integrin-mediated uptake of S. 
aureus requires β1 integrin-induced Src family phosphotyrosine kinase signaling events 
and actin remodeling (1).   
Yersinia pseudotuberculosis is a Gram-negative bacterium that causes 
tuberculosis-like symptoms in animals and fever and abdominal pain in humans after 
ingesting contaminated food products (198).  In mice, Yersinia can cause localized 
infection in the lymph nodes and fatal systemic disease.  Yersinia infects the intestine by 
binding to the apical surface of intestinal M cells.  Once bound, Y. pseudotuberculosis is 
internalized into M cells and translocated to underlying Peyer’s patches (160).  Bacterial 
translocation and attachment to epithelial cells is mediated by the bacterial membrane 
protein, invasin (197), which binds to β1 integrin to promote bacterial internalization 
(119).  Invasin binds to β1 integrin paired with a number of α subunits including α3, α4, 
α5, α6, and αv (119).  Binding and entry of Yersnia pseudotuberculosis into mouse 
intestinal M cells are dependent on invasin binding to β1 integrins expressed on the 
apical surface (59, 160).  Additionally, the β1 integrin cytoplasmic domain NPXY motifs 
are required for efficient bacterial uptake (106, 254) via a mechanism independent of 
tyrosine phosphorylation (106).  Therefore, β1 integrin is required for both binding and 
signaling events to enhance internalization of Y. pseudotuberculosis.   
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Significance of the Research 
 Viral entry into cells is a complex, multi-step process that initiates infection in the 
host.  Cell entry steps are poorly understood for most nonenveloped viruses including 
reovirus.  Internalization mechanisms used by nonenveloped viruses are likely to be 
conserved.  Thus, the use of reovirus as a model system to study viral attachment and 
internalization will provide a deeper understanding of virus entry for nonenveloped 
viruses.  Since viral attachment and cell entry play key roles in disease tropism, these 
studies also may enhance an understanding of how receptors function as host-cell 
determinants of viral pathogenesis and provide a framework for the development of 
antiviral therapies.  Moreover, information gained from work on virus-receptor 
interactions will allow a greater appreciation of the functions of these receptor molecules, 
including β1 integrin and JAM-A.  Finally, studies of integrin-mediated virus entry will 
contribute new information about the function of integrins in endocytosis and signaling 
and enhance knowledge of integrin-pathogen interactions.  My dissertation research has 
focused on identification and characterization of cell-surface receptors required for 
reovirus internalization.  This research has led to the identification of β1 integrin as a 
reovirus internalization receptor and elucidated the importance of the NPXY motifs in the 
β1 integrin cytoplasmic domain in functional reovirus entry.   
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CHAPTER II 
 
β1 INTEGRIN MEDIATES INTERNALIZATION OF MAMMALIAN REOVIRUS 
 
Introduction 
Viral attachment and cell entry are key determinants of target-cell selection in the 
infected host and thus play important roles in pathogenesis.  Many viruses interact with 
multiple cell-surface molecules to mediate the processes of attachment and internalization 
(231).  Receptors that serve as initial binding sites have been identified for many viruses 
(73).  However, little is known about the post-attachment events that lead to 
nonenveloped virus internalization and delivery into the endocytic pathway.  In particular 
the cellular determinants of reovirus receptor-mediated internalization following 
attachment and preceding uncoating are poorly defined. 
 We previously identified JAM-A as a serotype-independent receptor for reovirus 
(15, 43, 91).  JAM-A is a type 1 transmembrane protein expressed in a variety of cell 
types, including polarized endothelial and epithelial cells and circulating leukocytes (150, 
162, 266).  JAM-A interacts with several scaffolding proteins and cytoplasmic adaptor 
molecules (19, 79, 80) and is hypothesized to play an important role in maintaining 
barrier function of epithelial junctions (142, 150, 162, 188).  JAM-A is phosphorylated 
during platelet activation and required for mitogen-activated protein kinase activation 
following treatment of endothelial cells with basic fibroblast growth factor (174).  These 
data indicate that JAM-A is intimately associated with cytoskeletal and signaling 
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machinery, which raises the possibility that reovirus binding to JAM-A mediates 
cytoskeletal rearrangement or signaling events to facilitate virus internalization. 
 The attachment mechanisms of reovirus and adenovirus are remarkably similar 
(235, 236).  The trimeric attachment proteins of both viruses, σ1 and fiber, respectively, 
are structural homologues and fold using a highly unusual triple β-spiral motif (27, 53, 
276).  The globular head domains of these molecules are formed from eight-stranded β-
barrels with identical interstrand connectivity (235).  The receptors for σ1 and fiber, 
JAM-A (15) and CAR (23), respectively, are two-domain, immunoglobulin superfamily 
proteins that form homodimers using analogous molecular surfaces (236).  Both JAM-A 
and CAR localize to tight junctions in polarized epithelial cells (61, 150, 162, 188).  
Remarkably, reovirus and adenovirus engage their respective receptors by 
thermodynamically favored disruption of receptor homodimers (91, 151). 
 Despite mediating high-affinity attachment of adenovirus to cells, engagement of 
CAR does not permit efficient adenovirus internalization.  Instead, adenovirus entry is 
enhanced by high-avidity interactions of the viral penton base complex with integrins, 
including αvβ3 and αvβ5 (265).  Integrins function to mediate cellular adhesion to the 
extracellular matrix, regulate cellular trafficking, and transduce both outside-in and 
inside-out signaling events (117).  In addition to adenovirus, several other pathogenic 
microorganisms have usurped the adhesion and signaling properties of integrins to bind 
or enter host cells (4, 24, 89, 102, 103, 114, 123, 146). 
To define the molecular basis of reovirus internalization, we first tested the 
capacity of a JAM-A mutant lacking a cytoplasmic tail to support reovirus attachment 
and infection.  We found that, while JAM-A is necessary for efficient attachment to cells, 
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the JAM-A cytoplasmic tail is not required for reovirus infection.  Given the mechanistic 
conservation of reovirus and adenovirus attachment strategies, and the observation that 
reovirus outer-capsid protein λ2 contains conserved integrin-binding sequences RGD and 
KGE, we tested the role of integrins in reovirus internalization.  I found that infection by 
reovirus virions is inhibited by antibodies specific for β1 integrin.  In addition, cells 
deficient in β1 integrin have a diminished susceptibility to reovirus infection due to a 
post-attachment block to viral entry.  Together, these data indicate that following 
attachment to JAM-A, β1 integrin facilitates internalization of reovirus into cells.  These 
findings further demonstrate that two seemingly unrelated viruses utilize distinct cellular 
molecules to mediate attachment and internalization in a remarkably similar manner. 
When I began my dissertation research in the Dermody laboratory, Craig Forrest, 
a graduate student, had made the initial observation that the JAM-A cytoplasmic tail was 
not required for reovirus infection, and he hypothesized that integrins were required for 
reovirus internalization.  I acknowledge Craig for intellectual contributions, for 
generation of the JAM-A and JAM-A-ΔCT constructs, and for Figure 13.  I acknowledge 
Sarah Kopecky-Bromberg for assistance with confocal microscopy in Figure 14.   
 
Results 
The JAM-A Cytoplasmic Tail Is Dispensable for Reovirus Infection 
   JAM-A is a serotype-independent reovirus receptor with a cytoplasmic tail 
known to interact with a variety of cytoplasmic proteins (19, 79, 80).  To determine 
whether the JAM-A cytoplasmic tail is required for reovirus entry, we generated a JAM-
A cytoplasmic-tail deletion mutant (JAM-A-ΔCT) and tested its capacity to support 
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reovirus infection following transfection of Chinese hamster ovary (CHO) cells.  CHO 
cells do not express detectable levels of JAM-A (162, 188) and are poorly permissive for 
reovirus infection (43, 91).  Cells were transiently transfected with plasmids encoding 
full-length JAM-A, JAM-A-ΔCT, or empty vector as a control.  Equivalent cell-surface 
expression of transfected constructs was confirmed by flow cytometry (data not shown). 
The capacity of reovirus to infect CHO cells following transfection with the JAM-
A constructs was tested using reovirus fluorescent focus assays.  Following transient 
transfection of CHO cells with empty vector, JAM-A, or JAM-A-ΔCT, cells were 
adsorbed with reovirus strains T1L or T3D and scored for infection by indirect 
immunofluorescence at 20 h post-infection (Fig. 8).  Expression of either full-length or 
truncated JAM-A was sufficient to allow reovirus infection of CHO cells, permitting viral 
protein production of both type 1 and type 3 reovirus strains.  These results indicate that 
the JAM-A cytoplasmic tail is not required for efficient reovirus attachment and 
infection.   
 
Reovirus Outer-Capsid Proteins Contain Integrin-Binding Sequences 
  Structural and functional analyses indicate that reovirus and adenovirus share 
remarkably similar mechanisms of attachment (235, 236).  To determine whether 
reovirus outer-capsid proteins contain sequences that could potentially engage integrins, I 
performed a search for integrin-binding motifs in the σ1, σ3, μ1, and λ2 proteins, which 
form the reovirus outer capsid (76).  I identified two common integrin-binding motifs, 
RGD and KGE, in the deduced amino acid sequence of the λ2 protein (Fig. 9).  The RGD 
motif is conserved in all reovirus strains for which sequence information is available (37, 
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Fig. 8.  The JAM-A Cytoplasmic Tail Is Not Required for Reovirus Infection.  
CHO cells were transiently transfected with empty vector or plasmids encoding JAM-
A or JAM-A-ΔCT.  Following incubation for 24 h to permit receptor expression, cells 
were adsorbed with reovirus strains (A) T1L or (B) T3D at an MOI of 0.1 or 1 FFU 
per cell, respectively, at room temperature for 1 h.  Cells were washed with PBS, 
incubated in complete medium at 37°C for 20 h, and stained by indirect 
immunofluorescence.  Infected cells were quantified by counting cells exhibiting 
cytoplasmic staining in entire wells for triplicate experiments.  The results are 
expressed as the mean fluorescent focus units (FFU) per well for triplicate samples.  
Error bars indicate standard deviations.  
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225); the KGE motif is conserved in all of those strains except T2J (37, 225).  The λ2 
protein is a component of the reovirus outer capsid and core (76).  It is structurally 
arranged as a pentamer at the virion fivefold axes of symmetry and forms the base for 
attachment protein σ1 (76, 208) (Fig. 5).  The presence of conserved integrin-binding 
motifs in the reovirus λ2 protein led us to test whether reovirus utilizes integrins to 
mediate internalization.    
 
An Antibody Specific for β1 Integrin Inhibits Reovirus Infection of HeLa Cells 
  To determine whether integrins are required for reovirus infection, I first used 
flow cytometry to analyze integrin expression on the surface of HeLa cells.  HeLa cells 
were incubated with integrin-specific monoclonal antibodies (MAbs) and a PE-labeled 
secondary antibody (Table 1).  RGD-binding integrin subunits α3, α5, αv, and β1 and 
KGE-binding integrin subunits α1, α2, α6, and β1 (118) were detected on HeLa cells at 
levels above control antibody-treated cells.  RGD-binding integrin heterodimer αvβ5 also 
was detected at levels above control, while there was low-level expression of αvβ3.  
Thus, HeLa cells express both RGD- and KGE-binding integrins. 
To assess a role for integrins in reovirus replication, I tested antibodies specific 
for the RGD- and KGE-binding integrins expressed on HeLa cells for the capacity to 
block reovirus infection.  HeLa cells were preincubated with integrin-specific and control 
antibodies prior to adsorption with reovirus virions.  Viral infection was detected by 
indirect immunofluorescence (Fig. 10A).  I found that β1-specific MAb DE9 resulted in a  
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Table 1.  Surface expression of integrins on HeLa cells  
Antibody Specificity Mean fluorescence intensitya 
MAB1997 (IgG control) Murine β1 integrin 2.65 
MAB1973 Human α1 integrin 76.09 
MAB6F1 Human α2 integrin 84.47 
MAB2057 Human α3 integrin 73.31 
MABBIIG2 Human α5 integrin 76.68 
MAB1378 Human α6 integrin 81.86 
MAB1980 Human αv integrin 78.75 
MAB2253Z Human β1 integrin 61.14 
MAB1976 Human αvβ3 integrin 5.46 
MAB1961Z Human αvβ5 integrin 42.10 
 
a  Results are expressed as mean fluorescence intensity for an average of 14,000 gated events as 
assessed by flow cytometry.   
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 Fig. 9.  Reovirus Outer-Capsid Protein λ2 Contains Integrin-Binding Sequences.  
Alignment of deduced amino acid sequences of the reovirus λ2 protein for the 
indicated strains.  Amino acid residues are designated by the single-letter code.  
Amino acid positions are indicated above the first and last letter.  Integrin-binding (A) 
RGD and (B) KGE motifs are highlighted by a black box.  Non-conserved sequences 
are shown in unshaded boxes.  CON, consensus sequence. 
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50% reduction in infection (P < 0.05), while antibodies specific for the other integrin 
subunits expressed on HeLa cells had no effect.  Control antibodies produced anticipated 
effects; JAM-A-specific MAb J10.4 inhibited infection, whereas ICAM-specific MAb 
(data not shown) or control mouse ascites (Fig. 10A) did not.  The effect of MAb DE9 
was dose-dependent (Fig. 10B), providing further evidence that the inhibition of infection 
resulted from integrin blockade.   
To determine whether particular α subunits pair with β1 integrin to facilitate 
reovirus infection, I tested whether treatment with α integrin-specific antibodies was 
capable of enhancing the inhibitory effect of β1 integrin-specific MAb DE9 on reovirus 
infection.  I also tested whether antibodies specific for other β integrin subunits expressed 
on HeLa cells, β3 and β5, were capable of infection blockade.  HeLa cells were treated 
with MAb DE9 in combination with other integrin-specific antibodies prior to adsorption 
with reovirus virions (Fig. 10C).  While treatment of HeLa cells with MAb DE9 resulted 
in a 50% reduction in reovirus infection, none of the other integrin-specific antibodies 
tested reduced reovirus infection greater than that resulting from treatment with DE9 
alone.  These results suggest that the integrin epitope bound by reovirus is blocked by β1-
specific MAb DE9 and not by the other MAbs used in these experiments.   
JAM-A MAb J10.4 blocks reovirus infection ~90% (Fig. 10D).  To determine 
whether the residual level of infection in the presence of MAb J10.4 was dependent on 
reovirus interactions with β1 integrin, I treated HeLa cells with JAM-A-specific MAb 
J10.4 in combination with MAb DE9 prior to adsorption with reovirus virions (Fig. 10D).  
Treatment of HeLa cells with MAb J10.4 and MAb DE9 completely abrogated reovirus 
infection, indicating that the effect of JAM-A blockade is enhanced when β1 integrin is  
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Fig. 10.  β1 Integrin Antibody Reduces Reovirus Infection of HeLa Cells.  HeLa 
cells were treated with (A),gel saline (GS), control ascites (C), JAM-A-specific MAb 
J10.4, or antibodies specific for the α and β integrins shown (20 μg per ml or as 
diluted ascites), (B) gel saline, control ascites (Control), α2-specific MAb AA10, or 
β1-specific MAb DE9 (at the indicated dilutions), (C) antibodies specific for the α 
and β integrins shown in the presence of β1-specific MAb DE9 (1:10), control ascites, 
β1-specific MAb DE9, JAM-A-specific MAb J10.4, or (D) JAM-A-specific MAb 
J10.4 in combination with β1-specific MAb DE9  and incubated at room temperature 
for 1 h.  Antibody-treated cells were infected with virions or ISVPs of T1L at an MOI 
of 0.1 FFU per cell at 4°C for 30 min.  Cells were washed with PBS, incubated in 
complete medium at 37°C for 16 h, and stained by indirect immunofluorescence.  
Infected cells were quantified by counting cells exhibiting cytoplasmic staining in 
three fields of view for triplicate samples.  The results are expressed as the mean FFU 
per field for triplicate experiments.  Error bars indicate standard deviations.  *,  P < 
0.05 in comparison to control; **, P < 0.05 in comparison to HeLa cells treated with 
JAM-A-specific MAb J10.4 alone. 
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not available for interactions with reovirus.  Treatment with MAb DE9 did not 
significantly inhibit infection by ISVPs (Fig. 10D), suggesting that viral attachment is not 
affected by β1 integrin blockade.  Taken together, these results support the conclusion 
that a β1 integrin-specific antibody blocks reovirus infection at a step subsequent to 
attachment, but prior to uncoating, thereby implicating β1 integrin in reovirus 
internalization. 
 
Transient Transfection of Integrin cDNAs Allows Reovirus Infection of JAM-A-
Expressing CEFs 
 
Ectopic expression of JAM-A in chicken embryo fibroblasts (CEFs) rescues 
infection by reovirus ISVPs but not by virions (15), suggesting that these cells exhibit a 
cell-specific block at the entry or uncoating phases of reovirus infection.  To test the 
capacity of integrins to confer infection of CEFs by reovirus virions, CEFs were 
transiently transfected with a JAM-A-encoding plasmid in the presence or absence of 
murine αv, α2, or β1 integrin-encoding plasmids singly or in αβ pairs.  Transfected cells 
were infected with reovirus virions or ISVPs, and infection was assessed by indirect 
immunofluorescence (Fig. 11).  Expression of β1 integrin, paired with either of the 
murine α integrin subunits, provided an approximately four-fold enhancement of 
infection by reovirus virions in comparison to cells transfected with JAM-A alone.  These 
data suggest that β1 integrin complements a reovirus cell-entry defect in CEFs and 
provide further support for the involvement of β1 integrin in reovirus internalization. 
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Fig. 11.  β1 Integrin Expression Enhances Reovirus Infection of CEFs.  CEFs 
were transiently transfected with JAM-A-encoding plasmid alone (vector) or in 
combination with plasmids encoding the integrin subunits shown.  Following 24 h to 
allow receptor expression, transfected cells were adsorbed with T1L virions or ISVPs 
at an MOI of 1 FFU per cell at room temperature for 1 h.  Cells were washed with 
PBS, incubated in complete medium at 37°C for 20 h, and stained by indirect 
immunofluorescence.  Infected cells were quantified by counting cells exhibiting 
cytoplasmic staining in entire wells for duplicate samples.  The results are expressed 
as the mean FFU per well for duplicate experiments.  Error bars indicate the range of 
data.  Shown is a representative experiment of three independent experiments 
performed. 
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Cells Deficient in β1 integrin Have a Decreased Capacity to Support Reovirus 
Infection 
 
To further assess a role for β1 integrin in reovirus infection, I tested the capacity 
of reovirus to infect cells deficient in the β1-integrin subunit.  GD25 cells are murine 
embryonic stem cells derived from β1-null embryos (263).  GD25β1A cells are GD25 
cells that have been engineered to stably express β1 integrin and thus serve as an isogenic 
control for GD25 cells.  Flow cytometric analysis confirmed that while both cells express 
JAM-A, only GD25β1A cells express β1 integrin (Fig. 12A).  GD25 cells (β1-/-) and 
GD25β1A cells (β1+/+) (263) were adsorbed with reovirus virions or ISVPs, and 
infection was scored by indirect immunofluorescence (Fig. 12B).  In comparison to 
β1+/+ cells, β1-/- cells were substantially less susceptible to infection by virions, while 
infection by ISVPs was equivalent in both cell types.  Importantly, pre-incubation of 
β1+/+ cells with murine β1 integrin-specific MAb CD29 reduced infection in β1+/+ cells 
(Fig. 12C), indicating that enhancement of infection is due to expression of β1 integrin.  
Therefore, β1 integrin is required for efficient reovirus infection. 
 
Reovirus Binding to β1-/- and β1+/+ Cells Is Equivalent 
Equivalent infection of β1-/- and β1+/+ cells by ISVPs (Fig. 12B) suggests that 
reovirus is capable of efficiently binding to both cell types.  To directly test this 
hypothesis, β1-/- and β1+/+ cells were mock-treated or incubated with FITC-labeled 
virions and binding was assessed by flow-cytometry (Fig. 13).  In these experiments, we 
found that reovirus binds equivalently to β1-/- and β1+/+ cells.  These data demonstrate a 
function for β1 integrin in reovirus infection at a step subsequent to viral attachment. 
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Fig. 12.  Cells Deficient in β1 Integrin Are Less Permissive for Reovirus 
Infection.  (A) GD25 (β1 -/-) and GD25β1A (β1 +/+) cells were detached from plates 
with 20 mM EDTA, washed, and incubated with antibodies specific for either murine 
β1 integrin or murine JAM-A.  Cell-surface expression of these molecules was 
detected by flow cytometry.  Data are expressed as fluorescence intensity.  β1-/- and 
β1+/+ cells were (B) untreated or (C) pretreated with β1-specific MAb CD29 (β1 Ab) 
or a hamster isotype-matched control MAb (IgG) at room temperature for 1 h, 
adsorbed with virions or ISVPs of T1L at an MOI of 0.1 FFU per cell, and incubated 
at 4°C for 30 min.  Cells were washed with PBS, incubated in complete medium at 
37°C for 20 h, and stained by indirect immunofluorescence.  Infected cells were 
quantified by counting cells exhibiting cytoplasmic staining in five fields of view for 
triplicate samples.  The results are expressed as the mean FFU per field for triplicate 
experiments.  *, P < 0.05 in comparison to control. 
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Fig. 13.  Reovirus Exhibits Equivalent Binding to β1 -/- and β1 +/+ Cells.  β1 -/- 
and β1 +/+ cells were incubated with either PBS (mock) or 2 x 1011 FITC-labeled T1L 
virions at 4°C for 1 h and analyzed by flow cytometry to assess reovirus binding to the 
cell surface.  The results are expressed as fluorescence intensity. 
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β1 Integrin Enhances the Efficiency of Reovirus Internalization 
To directly assess the role of β1 integrin in reovirus internalization, β1-/- and 
β1+/+ cells were infected at 4°C and then warmed to 37°C over a time-course concurrent 
with reovirus entry (11, 239).  At 10-min intervals, cells were fixed, stained for reovirus 
using indirect immunofluorescence, and examined by confocal microscopy.  
Representative confocal micrographic images of reovirus-infected β1-/- and β1+/+ cells 
are shown in Fig. 14.  Immediately after viral adsorption, both cell types exhibited 
reovirus staining at the cell periphery.  At 10 min post-adsorption, some reovirus staining 
was observed at the cell periphery, yet intracellular staining in β1+/+ cells also was 
observed.  At 20 and 30 min post-adsorption, the majority of virions had entered the 
β1+/+ cells and had a perinuclear location.  In contrast, viral entry was markedly delayed 
in β1-/- cells, with the majority of reovirus virions remaining at the cell periphery 
throughout the time-course.  At later time-points (30 min post-adsorption), some virions 
were present within the cytoplasm, but these were the minority.  These findings suggest 
that expression of β1 integrin enhances reovirus entry.   
To quantify reovirus internalization into β1-/- and β1+/+ cells, we determined the 
number of internalized fluorescent particles as a percentage of the total number of 
fluorescent particles per cell at various times post-adsorption (Fig. 15).  At 0 and 10 min 
post-adsorption, the percentage of particles internalized into β1-/- and β1+/+ cells was 
equivalent, ~10% and ~30%, respectively.  However, at 20 and 30 min post-adsorption, 
the percentage of reovirus particles internalized into β1+/+ cells was ~50%, while the 
percentage of particles internalized into β1-/- cells was only ~30% (P < 0.05) (Fig. 15).   
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Fig. 14.  β1 Integrin Enhances Reovirus Entry into Cells.  (A) β1 +/+ and (B) β1 -
/- cells were chilled, adsorbed with T1L virions, and incubated at 4°C for 1 h.  Non-
adherent virus was removed, warm medium was added, and cells were incubated at 
37°C for the times shown.  Cells were fixed, stained for reovirus (green), actin (red), 
and DNA (blue), and imaged using confocal immunofluorescence microscopy.  
Representative digital fluorescence images of the same field are shown in each row.
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Fig. 14. - continued.  
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Fig. 15.  Quantification of Reovirus Internalization into β1 -/- and β1 +/+ 
Cells.  Viral internalization was quantitated by enumerating fluorescent particles 
localized at the cell periphery and particles internalized into the cytoplasm to 
determine the total number of fluorescent particles per cell.  The results are 
expressed as mean percent internalization (internalized fluorescent particles divided 
by the total number of fluorescent particles per cell) for 10 cells for each time point.  
*, P < 0.05 in comparison to β1 +/+ cells. 
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These data indicate that β1 integrin enhances reovirus entry at early times post-
adsorption, suggesting a direct role for β1 integrin as a reovirus internalization receptor. 
 
Discussion 
 In this study, we performed experiments to define molecular determinants of 
reovirus internalization.  Antibodies specific for β1 integrin inhibit reovirus infection at a 
post-attachment step.  Expression of β1 integrin promotes infection by reovirus virions in 
cells with a block to viral internalization, and viral entry is substantially diminished in 
cells deficient in β1 integrin expression.  Together, these data provide strong evidence 
that β1 integrin serves as a coreceptor to mediate reovirus internalization.  These findings 
engender a new model for attachment and cell entry of reovirus (Fig. 16).  In this model, I 
propose that reovirus initially interacts with cells via low-affinity binding to 
carbohydrate.  These interactions are followed by high-affinity engagement of JAM-A, 
which positions the virus on the cell surface for subsequent interactions with β1 integrin 
to trigger viral endocytosis.  Furthermore, the identification of β1 integrin as a reovirus 
internalization receptor suggests that the conservation of attachment strategies used by 
reovirus and adenovirus (235, 236) extends to mechanisms of internalization. 
Although the specific reovirus protein required for integrin binding is not 
apparent from our studies, the λ2 protein is a promising candidate.  The λ2 protein forms 
a pentameric turret at the virion fivefold symmetry axes and serves as the insertion site 
for trimers of attachment protein σ1 (76).  Thus, λ2 is the reovirus analogue of the 
adenovirus penton base protein, which mediates the engagement of integrins by 
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Fig. 16.  Model of Reovirus Attachment and Cell Entry.  Reovirus initially engages 
cells by low-affinity interactions with carbohydrate.  For type 3 reovirus strains, this 
carbohydrate is sialic acid.  Reovirus-carbohydrate interactions are followed by high-
affinity binding to JAM-A, which positions the virus on the cell surface for 
subsequent interactions with β1 integrin to trigger viral endocytosis. 
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adenovirus (56, 265).  Interestingly, λ2 also contains conserved RGD and KGE motifs 
(37), the preferred interaction motifs for several β1 integrin heterodimers (118).  
Structural information for λ2 is available in the context of the reovirus core but not for 
the intact virion (208).  In the core, the KGE motif is exposed on the top of the λ2 turret, 
where it would be accessible to a receptor (208).  The RGD motif is also surface exposed, 
but it appears to be less accessible.  However, the λ2 structure in the core may not be 
identical to that in the virion, as the protein undergoes major conformational changes 
during virion-to-core disassembly (76) (Fig. 5).  Therefore, it is possible that both the 
RGD and KGE motifs are accessible to interactions with β1 integrin during engagement 
of the cell surface by the virus.   
A human β1 integrin-specific antibody (DE9) reduced reovirus infection of HeLa 
cells by 50% (Fig. 10).  Similarly, a murine β1 integrin-specific antibody (CD29) blocked 
infection of β1-expressing mouse embryonic stem cells by ~50% (Fig. 12).  Interestingly, 
MAb DE9 also blocks infection of echovirus (24) and cytomegalovirus (89), suggesting 
that an epitope in β1 integrin recognized by MAb DE9 may be a preferred binding site 
for multiple viruses.  It is possible that the residual level of reovirus infection following 
β1 integrin antibody treatment is attributable to other internalization receptors on the cell 
surface that may be integrin or non-integrin molecules.  However, it is noteworthy that 
treatment of HeLa cells with both MAb DE9 and JAM-A-specific MAb J10.4 completely 
abolishes reovirus infection (Fig. 10D).  This finding suggests that the residual infection 
in J10.4-treated HeLa cells is due to reovirus interactions with β1 integrin.  Thus, it 
appears that blockade of reovirus infection by integrin-specific antibodies is inefficient 
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because complete inhibition of virus-integrin interactions is not possible if the virus is 
tightly adhered to the cell surface by JAM-A.   
Since antibodies specific for β3 and β5 integrins did not inhibit reovirus infection, 
it is likely that only β1 integrin can serve a reovirus internalization function.  Antibodies 
specific for the α integrin subunits expressed on HeLa cells did not further reduce 
reovirus infection following treatment with a β1 integrin-specific antibody (Fig. 10C).  I 
envision three possible explanations for this result.  First, reovirus may directly engage 
the ligand-binding I-like domain of β1 integrin.  Second, reovirus may utilize β1 integrin 
when paired with numerous α subunits that serve redundant functions.  However, 
treatment of HeLa cells with a β1 integrin-specific antibody and a mixture of antibodies 
specific for α1, α2, α3, α5, α6, and αv integrins did not diminish reovirus infection in 
comparison to cells treated with a β1 integrin-specific antibody alone (data not shown).  
Third, reovirus may engage an epitope of an integrin α subunit that is not recognized by 
the antibodies used in these experiments.  Further studies are required to define the 
biophysical basis of reovirus-integrin interactions. 
JAM-A is required for high-affinity reovirus attachment to numerous cell types 
(15, 43, 91, 165).  However, the JAM-A cytoplasmic tail is not necessary for viral 
endocytosis (Fig. 8).  JAM-A likely tethers the virus to the cell surface to facilitate 
secondary interactions with β1 integrin (Fig. 16).  This model is analogous to the 
mechanism of lymphocyte homing, in which adhesion molecules such as JAM-A provide 
initial cellular contacts to facilitate subsequent interactions with integrins for diapedesis 
or signaling (217).  An interesting possibility is that JAM-A may be associated with β1 
integrin on the host-cell plasma membrane.  If such were the case, initial JAM-A 
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engagement might facilitate integrin binding, clustering, and viral endocytosis.  In 
support of this hypothesis, JAM-A has been shown to regulate β1 integrin expression and 
localization (157). 
Identification of β1 integrin as a receptor that triggers reovirus entry raises the 
possibility that coreceptor binding influences reovirus tropism and disease.  Reovirus 
serotypes differ in mechanisms of spread, tropism for cells in the central nervous system, 
and disease outcome in the infected host (248).  Previous studies using reassortant 
genetics and comparative sequence analysis demonstrate that these phenotypes most 
strongly segregate with viral attachment protein σ1, suggesting that reovirus serotypes 
bind to different receptors (250, 259, 260).  However, the σ1-encoding S1 gene is not the 
sole determinant of reovirus growth at some sites within the host.  For example, the λ2-
encoding L2 gene influences viral growth in the intestine (28) and spread to new hosts 
(134).  Moreover, JAM-A functions as a receptor for all three reovirus serotypes (43); 
therefore, JAM-A cannot explain serotype-dependent differences in reovirus 
pathogenesis.  The presence or absence of particular integrins at distinct physiologic sites 
may critically influence the course of reovirus infection.  In support of a role for 
coreceptor utilization in reovirus growth, reovirus infection can occur in the absence of 
σ1 (48) or JAM-A (15), albeit at greatly reduced efficiency.  These findings highlight the 
complex nature of reovirus attachment and entry and suggest that reovirus tropism and 
pathogenesis are not dictated by primary receptor interactions alone.  It is possible that 
tropism and pathogenesis are determined by the concerted action of attachment and 
internalization receptors, perhaps not all of which have been discovered. 
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CHAPTER III 
 
TYROSINE-BASED SIGNALING MOTIFS IN THE β1 INTEGRIN CYTOPLASMIC 
TAIL ARE REQUIRED FOR FUNCTIONAL REOVIRUS ENTRY 
 
Introduction 
Many viruses utilize distinct cellular molecules to mediate attachment and 
internalization (161).  After reovirus binds to JAM-A (15, 43), internalization is 
facilitated by β1 integrin (156).  Although the precise mechanism of reovirus entry is not 
known, available evidence suggests that reovirus enters cells by receptor-mediated 
endocytosis (32, 33, 239).  Thin-section electron micrographs demonstrate reovirus 
particles internalized into electron-dense invaginations that resemble clathrin-coated pits 
and clathrin-coated vesicles (215).  In keeping with these data, experiments using video 
fluorescence microscopy indicate that reovirus colocalizes with clathrin during viral entry 
(85).  These findings suggest that reovirus internalization is clathrin-dependent, but it is 
not known whether clathrin is required for the uptake pathway that leads to productive 
infection.   
Reovirus undergoes proteolytic disassembly of the viral outer capsid in the 
endocytic pathway (33, 49, 228, 239).  Studies monitoring reovirus entry in real-time 
using fluorescently-labeled virions suggest that reovirus collects in endocytic vesicles 
(99).  Treatment of L cells with ammonium chloride, which raises the intracellular pH of 
endosomes (163) and lysosomes (181), blocks infection by virions but not by ISVPs 
(239), suggesting that viral disassembly is dependent on acidic pH.  Reovirus 
disassembly in fibroblasts requires acid-dependent cysteine-containing proteases 
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cathepsins B and L, which mediate removal of σ3 and cleavage of µ1 (77).  Cathepsins B 
and L generally reside in late endosomes or lysosomes (247), providing support for the 
contention that reovirus disassembly occurs in these endocytic compartments.   
Many receptors that mediate uptake of cargo contain amino acid sequences in 
their cytoplasmic domains that recruit components of the endocytic machinery and 
regulate sorting to endocytic compartments.  Endocytic sorting signals include tyrosine-
based motifs such as tyrosine-any residue-any residue-bulky hydrophobic residue 
(YXX∅) and NPXY or dileucine-based motifs such as aspartic acid-any residue-any 
residue-leucine-leucine (DXXLL) (31).  These linear sequences are recognized by 
adaptor proteins and clathrin (29, 30, 166, 168, 182).  The importance of NPXY motifs 
was discovered by Brown and Goldstein, who found that a naturally occurring mutation 
of the tyrosine residue in the NPXY motif of the low-density lipoprotein (LDL) receptor 
results in decreased internalization of LDL cholesterol.  This mutation causes familial 
hypercholesterolemia, a disorder in which LDL cholesterol levels are elevated leading to 
premature atherosclerosis (68).  The β1 integrin cytoplasmic domain contains two NPXY 
motifs (209) with tyrosine residues at amino acid positions 783 and 795 (209).   
In this study, I performed experiments to determine whether the β1 integrin 
NPXY motifs are involved in reovirus internalization.  I also investigated the transport 
pathway used by reovirus to reach the compartment used for disassembly.  Using β1-/- 
cells stably expressing β1 integrin with altered NPXY motifs, I found that the β1 integrin 
NPXY motifs are required for reovirus infection but not for attachment or internalization.  
Furthermore, I found that reovirus particles enter β1+/+ cells using a clathrin-dependent 
mechanism and are delivered to vesicles that morphologically resemble early and late 
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endosomes.  In contrast, particles are internalized into cells with altered NPXY motifs 
using a clathrin-independent process and have an altered intracellular localization.  These 
findings suggest that the β1 integrin NPXY motifs are required for functional reovirus 
entry and infection.     
I acknowledge Elvin Woodruff, Magnify, Inc., Vanderbilt University, for 
processing and acquisition of electron micrographs (Fig. 23).    
 
Results 
Reovirus Infection Is Diminished in Cells with Tyrosine-to-Phenylalanine Mutations 
in the β1 Integrin NPXY Motifs 
 
  To determine whether the NPXY motifs in the cytoplasmic domain of β1 integrin 
are required for functional reovirus entry, I tested the capacity of reovirus to infect cells 
with mutations in the β1 integrin NPXY motifs.  GD25 (β1-/-) cells are embryonic stem 
cells derived from β1-null embryos.  GD25β1A (β1+/+) cells stably express full-length, 
wild-type β1 integrin (263).  GD25β1AY783F (β1+/+Y783F), GD25β1AY795F 
(β1+/+Y795F), and GD25β1AY783F/Y795F (β1+/+Y783F/Y795F) are GD25 cells 
engineered to stably express β1 integrin in which the tyrosine residues of the NPXY 
motifs at amino acid positions 783 and 795 have been substituted with phenylalanine 
(262, 263).  I first confirmed the cell-surface expression of β1 integrin and JAM-A by 
β1-/-, β1+/+, β1+/+Y783F, β1+/+Y795F, and β1+/+Y783F/Y795F cells using flow 
cytometry (Fig. 17A).  Each of the cell types tested expressed equivalent levels of β1 
integrin, with the exception of β1-/- cells, and all cell types expressed JAM-A.  To 
directly assess reovirus attachment, β1-/-, β1+/+, β1+/+Y783F, β1+/+Y795F, and  
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Fig. 17.  Reovirus Exhibits Equivalent Binding to β1-/-, β1+/+, and β1+/+ Cells 
with Altered NPXY Motifs.  (A) GD25 (β1 -/-), GD25β1A (β1 +/+), 
GD25β1AY783F (β1+/+Y783F), GD25β1AY795F (β1+/+Y795F), and 
GD25β1AY783F/Y795F (β1+/+Y783F/Y795F) cells were detached from plates with 
20 mM EDTA, washed, and incubated with antibodies specific for either murine β1 
integrin or murine JAM-A.  Cell-surface expression of these molecules was detected 
by flow cytometry.  Data are expressed as fluorescence intensity.  (B) β1 -/-, β1 +/+, 
β1+/+Y783F, β1+/+Y795F, and β1+/+Y783F/Y795F cells were detached from plates 
with 20 mM EDTA, washed, and incubated with 1 x 104 particles per cell of reovirus 
strain T1L at 4°C for 1 h to allow attachment.  Cells were washed and then incubated 
with reovirus specific antiserum or an IgG control antibody.  Reovirus binding was 
detected by flow cytometry.  Data are expressed as fluorescence intensity. 
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β1+/+Y783F/Y795F cells were incubated with reovirus particles, and binding was 
detected using flow cytometry (Fig. 17B).  Reovirus bound equivalently to all cell types, 
suggesting that reovirus attachment is not affected by mutation of the β1 integrin NPXY 
motifs to NPXF.   
 To determine whether mutations in the β1 integrin NPXY motifs alter reovirus 
infection, β1-/-, β1+/+, β1+/+Y783F, β1+/+Y795F, and β1+/+Y783F/Y795F cells were 
adsorbed with reovirus virions or ISVPs, and infectivity was scored by indirect 
immunofluorescence (Fig. 18).  In comparison to β1+/+ cells, β1-/-, β1+/+Y783F, 
β1+/+Y795F, and β1+/+Y783F/Y795F cells were less susceptible to infection by reovirus 
virions (Fig 18).  While reovirus infection was significantly reduced in β1+/+Y783F and 
β1+/+Y795F cells, infection was most dramatically reduced in β1+/+Y783F/Y795F cells, 
to an extent even greater than in β1-/- cells (Fig. 18).  ISVPs, which bind to JAM-A (15) 
but bypass a requirement for endocytosis and disassembly (11, 239), were capable of 
infection in all cell types.  Equivalent infection by ISVPs suggests that the block to 
reovirus infection in cells expressing mutant β1 integrin is at a step subsequent to 
attachment but preceding disassembly.   
 
Reovirus Virions Are Internalized into the Cytoplasm of β1+/+Y783F/Y795F Cells 
 To determine whether the block to reovirus infection in β1+/+Y783F/Y795F cells 
is due to a defect in internalization, β1-/-, β1+/+, and β1+/+Y783F/Y795F cells were 
adsorbed with reovirus particles at 4°C for 1 h to allow virus binding and then warmed to 
37°C to allow internalization over a time course concurrent with reovirus entry.  At 15-
min intervals, cells were fixed, stained using indirect immunofluorescence, and examined  
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Fig. 18.  Reovirus Infection is Diminished in Cells with Altered β1 Integrin 
NPXY Motifs.  β1-/-, β1+/+, β1+/+Y783F, β1+/+Y795F, and β1+/+Y783F/Y795F 
cells were adsorbed with reovirus virions or ISVPs of strain T1L at an MOI of 1 FFU 
per cell at 4°C for 1 h.  Cells were washed with PBS, incubated in complete medium 
at 37°C for 20 h, and stained by indirect immunofluorescence.  Infected cells were 
quantified by counting cells exhibiting cytoplasmic staining in entire wells for 
triplicate experiments.  The results are expressed as the mean FFU per well for 
triplicate samples.  Error bars indicate standard deviations.  *, P < 0.05 in comparison 
to β1+/+ cells. 
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by confocal microscopy.  Representative confocal micrographs of β1-/-, β1+/+, and 
β1+/+Y783F/Y795F cells infected with reovirus and fixed at 30 min post-adsorption are 
shown in Fig. 19A.  Reovirus particles were observed in the cytoplasm of all cell types, 
with a notable decrease in β1-/- cells, as observed previously (Chapter II).  Surprisingly, 
reovirus particles were internalized into both β1+/+ and β1+/+Y783F/Y795F cells (Fig. 
19A).  To determine whether the reovirus particles in β1+/+Y783F/Y795F cells were 
uniformly distributed, I collected multiple confocal micrographs in the Z-plane and 
examined them using Z-stack analysis and 3D image reconstructions (data not shown).  
This experiment indicated that reovirus particles were distributed throughout the non-
nuclear compartment of β1+/+Y783F/Y795F cells in a pattern similar to β1+/+ cells (data 
not shown).  To directly quantify the fluorescence intensity of internalized reovirus 
particles, confocal micrographs of images collected over a time course were analyzed 
using Metamorph software (Fig. 19B).  The average pixel intensity representing reovirus 
particles was equivalent in β1+/+ and β1+/+Y783F/Y795F cells, while pixel intensity 
was significantly less in β1-/- cells, suggesting that an equivalent number of particles are 
internalized into β1+/+ and β1+/+Y783F/Y795F cells.   
 
Viral Particles Internalized into β1+/+Y783F/Y795F Cells Are Not Functional  
 Although reovirus particles are internalized into β1+/+Y783F/Y795F (Fig. 19), 
these cells do not become infected (Fig. 18).  This finding suggests that productive 
reovirus internalization and endocytic trafficking requires intact NPXY motifs.  To 
determine whether input particles are capable of initiating transcription, cells were 
adsorbed with reovirus virions and incubated for 3.5 h.  RNA was purified from infected  
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Fig. 19.  Reovirus Is Internalized into β1+/+ and β1+/+Y783F/Y795F Cells.  
β1-/-, β1+/+, β1+/+Y783F/Y795F cells were adsorbed with T1L virions, and 
incubated at 4°C for 1 h.  Non-adherent virus was removed, warm medium was 
added, and cells were incubated at 37°C.  Cells were fixed, stained for reovirus 
(green), actin (red), and DNA (blue), and imaged using confocal 
immunofluorescence microscopy.  Images were collected on a Zeiss LSM510 
microscope with Meta software.  (A) Representative digital fluorescence images of 
cells fixed at 30 min post adsorption are shown.  Scale bars, 10μm.  (B) Reovirus 
internalization was quantitated by Metamorph software.  Fluorescent particles 
localized at the cell periphery were excluded from analysis and particles 
internalized into the cytoplasm were analyzed to determine the average pixel 
intensity of fluorescent particles per cell and multiplied by cell area for total pixel 
intensity.  The results are expressed as pixel intensity for 5 cells at each time point.  
*, P < 0.05 in comparison to β1 -/- cells. 
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cells and used as template for reverse transcriptase-polymerase chain reaction (RT-PCR) 
with primers specific for β-actin (control) or the reovirus L1 gene.  Resultant RT-PCR 
products were subjected to agarose gel electrophoresis and visualized following ethidium 
bromide staining.  In comparison to β1-/- cells, amplicon band intensity was greater in 
both β1+/+ and β1+/+Y783F/Y795F cells (Fig. 20).  To determine whether the viral 
RNA detected by RT-PCR represents viral genomic dsRNA or newly synthesized viral 
mRNA, cells were infected in the presence and absence of ribavirin, which blocks viral 
transcription (206) (Fig. 20).  Reovirus RNA levels were diminished in ribavirin-treated 
β1+/+ cells, suggesting that the RNA detected is newly synthesized viral RNA.  
However, ribavirin treatment did not diminish reovirus RNA levels in 
β1+/+Y783F/Y795F cells, suggesting that the RNA detected represents an accumulation 
of genomic dsRNA from input viral particles that do not undergo disassembly.  These 
data suggest that decreased reovirus infectivity in β1+/+Y783F/Y795F cells results from 
a block in the replication cycle prior to viral transcription.   
 
Reovirus Uptake into β1+/+ Cells is Clathrin-Dependent 
 To determine whether clathrin-mediated endocytosis is required for functional 
reovirus entry, β1+/+ cells were treated with chlorpromazine, a pharmacologic agent that 
inhibits clathrin assembly at the cell surface (258), and infected with reovirus virions or 
ISVPs (Fig. 21).  Chlorpromazine treatment blocked infection by virions but not by 
ISVPs, suggesting that chlorpromazine affects a step in reovirus infection that occurs 
after attachment but before disassembly.  Failure of chlorpromazine to inhibit infection 
by ISVPs also indicates that the concentration of chlorpromazine does not affect 
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Fig. 20.  Virus Particles Internalized into β1+/+Y783F/Y795F Cells Are Not 
Functional.    
β1-/-, β1+/+, β1+/+Y783F/Y795F cells were plated in 60 mm dishes, infected with 
reovirus virions of strain T1L, incubated at 4°C for 1 h, washed, and then complete 
medium with or without ribavirin (200μM) was added and cells were incubated at 
37°C for 0 or 3.5 h.  Cells were washed, harvested, and pelleted.  RNA was isolated 
from cell pellets and used as template for RT-PCR using primers specific for β-actin 
(control) (left) or reovirus L1 gene (right).  RT-PCR products were subjected to 
agarose gel electrophoresis and stained with ethidium bromide.  A representative 
agarose gel is shown.  β-actin transcripts are shown on the left and reovirus transcripts 
are shown on the right.  
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Fig. 21.  Reovirus Uptake into β1+/+ Cells Is Clathrin Dependent.  β1 +/+ cells 
were pre-treated with 5μg/mL of chlorpromazine for 3 h, infected with reovirus 
virions or ISVPs of strain T1L and incubated at 4°C for 1 h, washed, and complete 
medium with or without chlorpromazine was added, and cells were incubated at  37°C 
for 20 h.  Cells were fixed and stained by indirect immunofluorescence.  Infected cells 
were quantified by counting cells exhibiting cytoplasmic staining in entire wells for 
triplicate experiments.  The results are expressed as the mean FFU per well for 
triplicate samples.  Error bars indicate standard deviations.  *, P < 0.05 in comparison 
to untreated cells. 
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 the capacity of cells to support the reovirus replication program.   
 
The β1 Integrin NPXY Motifs Are Required for Functional Reovirus Uptake 
 To determine the role of the β1 integrin NPXY motifs in clathrin-dependent 
reovirus endocytosis, β1+/+ and β1+/+Y783F/Y795F cells were either treated with 
chlorpromazine or left untreated, infected with reovirus particles at 4°C for 1 h to allow 
attachment, and then warmed to 37°C to allow internalization.  At 0 and 20 min post-
adsorption, cells were fixed, stained using indirect immunofluorescence, and examined 
by confocal microscopy.  Representative confocal micrographs of β1+/+ and 
β1+/+Y783F/Y795F cells at 20 min post-infection are shown in Fig. 22A.  The 
fluorescence intensity of reovirus particles internalized into β1+/+ and 
β1+/+Y783F/Y795F cells was quantified by averaging the pixel intensity for 
representative confocal micrograph images using Metamorph software (Fig. 22B).  In 
β1+/+ cells treated with chlorpromazine, the average pixel intensity representing reovirus 
particles was significantly diminished in comparison to untreated β1+/+ cells (Fig. 22B), 
consistent with the infectivity data.  However, chlorpromazine treatment did not diminish 
the pixel intensity in β1+/+Y783F/Y795F cells in comparison to untreated cells, 
indicating that reovirus internalization into β1+/+Y783F/Y795F cells is not affected by 
chlorpromazine (Fig. 22B).  However, chlorpromazine treatment altered the intracellular 
distribution of reovirus particles in β1+/+Y783F/Y795F cells (Fig. 22A).  Thus, the 
reovirus uptake pathway in β1+/+ cells is chlorpromazine-sensitive, most likely clathrin-
dependent endocytosis, while reovirus internalization into β1+/+Y783F/Y795F cells is 
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Fig. 22.  β1 Integrin NPXY Motifs Are Required for Functional Reovirus 
Internalization.  β1 +/+ and β1+/+Y783F/Y795F cells were pre-treated with 
5μg/mL of chlorpromazine for 3 h, infected with reovirus virions of strain T1L 
and incubated at 4°C for 1 h, washed, and complete medium with or without 
chlorpromazine was added, and cells were incubated at  37°C for 0 or 20 min.  
Cells were fixed and stained by indirect immunofluorescence and analyzed by 
confocal microscopy.  Images were collected on a Zeiss LSM510 microscope with 
Meta software.  (A) Representative confocal micrographs of untreated and 
chlorpromazine-treated cells at 20 min post adsorption are shown.  Scale bars, 
10μm.  (B) Reovirus internalization into untreated and chlorpromazine-treated 
cells at 20 min post adsorption was quantitated by Metamorph software.  
Fluorescent particles localized at the cell periphery were excluded from analysis 
and particles internalized into the cytoplasm were analyzed to determine the 
average pixel intensity of fluorescent particles per cell and multiplied by cell area 
for total pixel intensity.  The results are expressed as pixel intensity for 10 cells at 
each time point.  *, P < 0.05 in comparison to untreated cells. 
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mediated by an alternative uptake mechanism that does not give rise to infectious 
progeny.   
Intracellular Trafficking Pathway of Reovirus Virions  
 To define the fate of reovirus virions in the endocytic compartment during 
internalization and disassembly, I performed an ultrastructural analysis of reovirus-
infected cells.  β1-/-, β1+/+, and β1+/+Y783F/Y795F cells were infected with reovirus, 
incubated at 37°C for 10-min intervals for 30 min, and processed for electron 
microscopy.  Fewer reovirus particles appeared within β1-/- cells in comparison to β1+/+ 
and β1+/+Y783F/Y795F cells.  In β1+/+ cells, and to a much lesser extent in β1-/- cells, 
a few reovirus particles were localized in coated-pit structures, while most particles 
appeared in structures that morphologically resemble early and late endosomes and 
lysosomes (Fig. 23).  In β1+/+Y783F/Y795F cells, reovirus particles were observed in 
coated-pit structures, yet few particles were observed in structures that resemble 
endosomes.  Instead, the majority of reovirus particles in β1+/+Y783F/Y795F cells 
appeared to coalesce in dark vesicular structures of unknown origin (Fig. 23).  These 
structures were found in all cell types, yet there appeared to be a greater number of these 
structures in the β1+/+Y783F/Y795F cells (Fig. 23).  While the nature of these cellular 
organelles is unclear, they do not appear to support reovirus disassembly.    
  
Discussion 
The goal of this study was to gain a better understanding of mechanisms by which 
β1 integrin mediates reovirus internalization.  The data demonstrate a function for the β1  
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Fig. 23.  Intracellular Trafficking of Reovirus Particles Is Altered in 
β1+/+Y783F/Y795F Cells.  β1-/-, β1+/+ and β1+/+Y783F/Y795F cells were infected 
with 1x105 particles of reovirus T1L per cell at 4°C for 1 h, washed, and fixed or 
incubated in complete medium at 37°C.  At 10-min intervals cells were washed, 
pelleted, and fixed.  Cells were processed for electron microscopy and images were 
captured on a Phillips CM10 Transmission Electron Microscope equipped with an 
AMT 2 mega pixel camera.  Representative EM images at 0, 10, and 20 min post 
infection are shown.  Reovirus Particles are ~90nm, with electron dense centers.  
Scale bars, 500nm.   
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integrin NPXY motifs in reovirus endocytosis and endocytic transport.  Tyrosine-to-
phenylalanine mutations of the β1 integrin NPXY motifs lead to an aberrant pathway of 
reovirus internalization that does not yield infectious particles.  Using EM analysis, I 
found that reovirus virions are internalized into β1+/+Y783F/Y795F cells yet localize in 
an undefined cellular compartment, rather than in endosomes and lysosomes as they do in 
β1+/+ cells.  Reovirus internalization into β1+/+ cells is mediated by a chlorpromazine-
sensitive pathway, most likely clathrin-dependent endocytosis, yet particles internalize 
into β1+/+Y783F/Y795F cells by a different route.  Collectively, these data indicate that 
β1 integrin serves to deliver reovirus to the proper endocytic compartment required for 
subsequent steps in the viral life cycle.  A model of β1 integrin-mediated reovirus 
internalization is shown in Fig. 24.  
NPXY motifs in the cytoplasmic domain of the LDL receptor (55, 68) and β 
integrin subunits (31) function in clathrin-dependent endocytosis.  NPXY motifs recruit 
clathrin or adaptor proteins such as AP-2 (30) or Dab2 (168, 183) to the cell surface, 
which leads to accumulation and assembly of clathrin at the plasma membrane (183).  
NPXY motifs can recruit AP-2 by directly interacting with the AP-2 μ2 subunit, which 
selects proper cargo for endocytosis (30).  The AP-2 β2 subunit binds clathrin subunits 
(187) and initiates clathrin assembly at the plasma membrane, resulting in clathrin-
mediated endocytosis.  NPXY motifs also can recruit Dab2 (168, 183), which directly 
interacts with NPXY motifs via the Dab2 PTB domain (166).  Dab2 can induce clathrin-
mediated endocytosis by either directly binding to clathrin (166) or binding to AP-2 
(169).  Therefore, it is possible that mutation of the β1 integrin NPXY motifs results in  
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Fig. 24. Model of β1 Integrin-Mediated Reovirus Internalization.  Reovirus 
activates β1 integrin, which contains NPXY motifs in the cytoplasmic domain.  The 
NPXY motifs are required for functional reovirus infection.  NPXY motifs could 
mediate reovirus internalization by interaction with adaptor proteins, AP-2 or Dab2, 
which could recruit clathrin the plasma membrane, leading to reovirus endocytosis.  
NPXY motifs are also required for reovirus trafficking in the endocytic pathway to 
endosomes and lysosomes where reovirus disassembly is thought to occur.  
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failure of the β1 integrin cytoplasmic domain to recruit the proper endocytic machinery 
for clathrin-dependent reovirus uptake.   
NPXY motifs also serve as cargo recognition motifs, which direct the delivery of 
cargo to endosomes and lysosomes (31, 166).  Thus, mutation of the β1 integrin NPXY 
motifs also may lead to improper delivery of reovirus to a functional endocytic 
compartment independent of an alteration in clathrin-dependent uptake.  In support of 
this possibility, Dab2 recognizes non-phosphorylated tyrosines of the NPXY motif (166, 
168).  Thus, in β1+/+Y783F/Y795F-infected cells, Dab2 could potentially engage β1 
integrin with NPXY-to-F mutations and mediate reovirus internalization but direct 
particles to a non-functional endocytic compartment.  Reovirus infection requires acid-
dependent proteolytic disassembly (11, 77, 239).  Thus, delivery to an intracellular site 
other than an endosomal compartment containing the appropriate pH (239) and enzymes 
(77) could result in failure of reovirus particles to uncoat.   
In addition to the role of NPXY motifs in diseases such as familial 
hypercholesterolemia, naturally occurring mutations in adaptor proteins that engage 
NPXY motifs also have been associated with certain pathological states.  For example, 
autosomal recessive hypercholesterolemia (ARH) is a rare disorder in which LDL is not 
effectively cleared from the bloodstream (108).  LDL is normally removed by the liver 
via binding to LDL receptors.  Bound LDL is rapidly internalized by clathrin-dependent 
endocytosis (6, 7, 40, 101) through interactions of Dab2 with the LDL NPXY motif, 
which leads to recruitment of AP-2 (168).  Although symptoms of ARH parallel those in 
familial hypercholesterolemia, the LDL receptors in ARH patients are normal (108).  
Instead, ARH is caused by mutations in a gene encoding an adaptor protein called ARH 
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(97).  ARH incorporates a PTB domain that directly engages the NPXY motif in the LDL 
receptor cytoplasmic domain and binds to the AP-2 β2 subunit and clathrin heavy chain 
to induce clathrin-mediated endocytosis of the LDL receptor following binding by LDL 
(98, 112, 167).  Mutations in ARH that affect binding to the NPXY motif of the LDL 
receptor or interactions with AP-2 or clathrin result in inefficient clearance of LDL and 
elevated serum cholesterol (98).   
Substitution of the β1 integrin NPXY-motif tyrosines with phenylalanines, which 
cannot be phosphorylated, results in reovirus delivery to a cellular compartment that does 
not support infection.  This finding raises the possibility that reovirus interactions with β1 
integrin lead to tyrosine phosphorylation of the NPXY motifs.  While it has been 
challenging to demonstrate β1 integrin tyrosine phosphorylation, v-src transformation of 
β1+/+ but not β1+/+Y783F/Y795F cells results in phosphorylation of β1 integrin (218), 
suggesting that NPXY tyrosines can serve as targets for phosphorylation.  It is possible 
that phosphorylation of the β1 integrin NPXY motifs is required for downstream 
signaling events required for reovirus endocytosis.  For example, phosphorylation of the 
NPXY tyrosine residues is required for autophosphorylation of FAK (261).  Thus, it is 
possible that reovirus-β1 integrin interactions induce phosphorylation and activation of 
integrin-linked signaling pathways. 
Studies presented in this chapter identify residues in the β1 integrin cytoplasmic 
domain that function in reovirus endocytosis and delivery of internalized virions to the 
endocytic compartment where disassembly occurs.  Furthermore, these findings describe 
how a nonenveloped virus usurps the normal physiologic function of integrins to mediate 
internalization.  Integrins are required for internalization of many pathogenic 
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microorganisms (24, 89, 114, 119, 175, 211, 265).  Therefore, understanding mechanisms 
by which integrins engage endocytic machinery to mediate endocytosis of microbes 
provides a framework for the rational design of antiviral drugs that target pathogen 
internalization via integrin-linked pathways.  
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CHAPTER IV 
 
SUMMARY AND FUTURE DIRECTIONS 
 
Introduction 
 The virus life cycle begins with viral attachment to cellular receptors and 
internalization into host cells.  Virus attachment and entry mechanisms can be cell type 
specific and, thus, these early replication events can influence viral tissue tropism and 
pathogenesis.  Although progress has been made in understanding virus receptor selection 
and engagement, little is known about mechanisms by which nonenveloped viruses enter 
cells.  An understanding of virus cell entry is important for development of molecular 
models of virus tropism and design of antiviral therapeutics to inhibit viral entry.  The 
goal of my dissertation research was to identify the receptor responsible for mediating 
reovirus internalization and to define mechanisms by which reovirus enters cells.  
Findings presented in this thesis provide evidence that β1 integrin mediates reovirus 
internalization (Chapter II) and that β1 integrin cytoplasmic domain NPXY motifs are 
required for internalization of reovirus to a functional endosomal compartment (Chapter 
III).  This chapter summarizes the findings presented herein and provides insights into 
future directions for this research.   
 
The Role of β1 Integrin in Reovirus Internalization 
 Data presented in Chapter II provide evidence that reovirus utilizes β1 integrin to 
mediate internalization.  However, it remains to be determined how β1 integrin serves 
74
this function.  The presence of integrin-binding motifs RGD and KGE in the reovirus λ2 
protein suggests that reovirus directly engages integrins.  I envision that following 
reovirus binding to JAM-A on the cell surface, the virus undergoes conformational 
changes that allow engagement of β1 integrins.  In support of this model, the σ1 
attachment protein binds to the D1 domain of JAM-A with a KD of 10-8M (15, Guglielmi, 
K.M. and Dermody, T.S., submitted).  The σ1 protein contains a “hinge” region in the 
fibrous tail below the head that introduces substantial flexibility between head and tail 
(53).  After σ1 binds to JAM-A, conformational changes in σ1 may allow movement of 
the virion about the surface of the cell.  Such movement may position the virus so that the 
λ2 protein, which contains surface-exposed RGD and KGE motifs (208), could engage 
β1 integrins, presumably via the I-like domain (205, 246).  Future directions described 
here could be used to determine whether and how reovirus engages β1 integrin.   
 To test whether λ2 RGD and KGE motifs are involved in integrin interactions, the 
newly-developed, plasmid-based, reverse genetics system (135) should be employed to 
generate mutant viruses with alterations in these sequences.  These viruses should be 
compared to wild-type viruses for cell attachment by flow cytometry, entry by confocal 
microscopy, and infectivity by FFU assay.  Furthermore, ISVPs of both wild-type and 
mutant viruses, generated by treatment of virions with protease in vitro, should be used as 
positive controls for infection.  I anticipate that altering the RGD or KGE motifs in λ2 
will reduce entry and infection by virions but not by ISVPs.  Although the presence of 
RGD and KGE motifs in λ2 provide rationale for studies of reovirus-integrin interactions, 
it is important to consider the possibility that reovirus engages integrins in an RGD- and 
KGE-independent manner.   
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 It is reasonable to hypothesize that reovirus directly engages the β1 integrin I-like 
domain.  To test this hypothesis, virions should be tested for the capacity to bind to 
recombinant β1 integrin using surface plasmon resonance (SPR).  Recombinant integrin 
heterodimers, α5β1 and α3β1 are commercially available and functional (R&D Systems 
Inc., Minneapolis, MN).  Integrin heterodimers should be captured on the surface of a 
biosensor chip (15), and purified virions of wild-type or RGD and KGE mutants, in a 
range of concentrations, should be injected across the biosensor surface to measure 
association and dissociation rates.  These experiments will provide a detailed assessment 
of interaction kinetics and affinity and permit direct comparison of reovirus-β1 integrin 
binding interactions between wild-type and mutant virus strains.  I anticipate that wild-
type virions will directly bind to integrin heterodimers, and mutant viruses may not bind 
to integrins or bind with diminished affinity.  If reovirus binding to β1 integrin 
heterodimers is detected, then studies should be performed to determine if reovirus 
directly engages the β1 integrin I-like domain.  Recombinant β1 integrin I-like domain 
should be expressed, purified, and subjected to site-directed mutagenesis to determine the 
residues required for reovirus binding.  The capacity of reovirus to bind mutant β1 
integrin I-like domains can be tested using SPR, and infectivity can be tested using β1-/- 
cells expressing wild-type β1 and β1 integrin with altered I-like domain sequences.  
These experiments will identify residues required for reovirus-β1 integrin engagement.   
 While I find it most likely that reovirus directly engages β1 integrin, it is entirely 
possible that reovirus engages an α subunit.  There are a number of explanations for the 
finding that α integrin-specific antibodies did not inhibit reovirus infection, most of 
which are described in Chapter II.  I did not test a complete panel of α integrin-specific 
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antibodies.  Therefore, I think a very careful characterization of a role for an integrin α 
subunit in reovirus infection should be performed using antibodies to additional α 
subunits capable of pairing with β1, as well as antibodies that recognize different 
epitopes in integrin α subunits.   
 Although direct engagement of integrins by reovirus seems to be the most likely 
scenario, it remains possible that reovirus does not directly bind to integrins.  Instead, 
reovirus binding to JAM-A may trigger interactions between JAM-A and integrins to 
mediate internalization.  In support of this hypothesis, various JAM family members can 
interact with integrins in a number of cellular processes (174, 184, 220).  Interestingly, 
JAM-A has been reported to regulate the cell-surface expression of β1 integrin (157).  To 
test whether β1 integrin and JAM-A directly interact during reovirus entry, cells should 
be infected, harvested over a time course of reovirus entry, and subjected to 
immunoprecipitation for JAM-A, followed by immunoblotting for β1 integrin.  To 
determine whether JAM-A and β1 integrin interact through extracellular, transmembrane, 
or cytoplasmic regions, chimeric molecules of JAM-A and CAR should be generated and 
expressed in CHO cells (204) with wild-type β1 integrin or chimeric molecules 
comprised of β1 integrin with another β integrin subunit.  These studies would provide 
evidence that β1 integrin mediates reovirus entry by a mechanism involving JAM-A.   
 
The Role of the β1 Integrin Cytoplasmic Domain in Reovirus Internalization 
The NPXY motifs of the β1 integrin cytoplasmic domain are required for reovirus 
infection.  Cells expressing NPXY-to-NPXF β1 mutants do not support infection by 
reovirus virions but do so by ISVPs (Chapter III).  Reovirus is internalized into cells 
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expressing β1 integrin NPXF mutants, but the particles are delivered to a compartment 
that is non-functional for reovirus infection (Chapter III).  This finding indicates that β1 
integrin NPXY motifs regulate reovirus delivery via a clathrin-dependent endocytic 
pathway.   
Adaptor proteins function in clathrin-dependent endocytosis to recognize the 
cytoplasmic tails of receptors and mediate clathrin assembly at the plasma membrane.  
While there are multiple adaptor proteins that may function in reovirus internalization, it 
is reasonable to hypothesize that AP-2 or Dab-2 mediate reovirus internalization based on 
their known interactions with NPXY motifs (166, 168).  To determine whether β1 
integrin is linked to clathrin and whether adaptor proteins are required for reovirus 
uptake, β1+/+ and β1+/+Y783F/Y795F cells should be treated with siRNAs 
corresponding to murine AP-2, Dab2, or clathrin (Dharmacon, Chicago, IL) to inhibit 
their endogenous expression.  siRNA-treated cells should be infected with reovirus 
virions and ISVPs, and reovirus entry should be analyzed by confocal microscopy and 
infectivity by FFU assay (156).  I anticipate that cells treated with AP-2, Dab2, or clathrin 
siRNA will exhibit a decrease in internalized reovirus particles.  To determine whether 
β1 integrin colocalizes with clathrin and adaptor proteins during reovirus internalization, 
confocal microscopic analysis should be performed.  β1+/+ and β1+/+Y783F/Y795F 
cells should be infected with reovirus, fixed over a time course of reovirus entry, and 
stained with antibodies specific for reovirus, β1 integrin, AP-2, Dab2, and clathrin.  
Images should be analyzed for the internalization of reovirus particles and colocalization 
of reovirus and β1 integrin with AP-2, Dab2, and clathrin using Metamorph software.  To 
determine whether reovirus uptake leads to direct association of β1 integrin with 
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endocytic adaptor proteins, biochemical techniques should be employed.  Cells should be 
infected with reovirus, harvested over a time course, and subjected to 
immunoprecipitation using a β1 integrin-specific antibody.  Resultant complexes should 
be resolved by SDS-PAGE and immunoblotted using AP-2- and Dab2-specific 
antibodies.  These experiments, with the utilization of the β1+/+Y783F/Y795F cells as a 
control, will define the function of the NPXY motifs in the recruitment of cellular 
machinery required for clathrin-mediated reovirus uptake. 
 Tyrosine-to-phenylalanine mutations of the β1 integrin NPXY motifs have 
unfavorable effects on reovirus infection.  This finding suggests that tyrosine 
phosphorylation of β1 integrin or downstream integrin-linked tyrosine kinases function in 
reovirus entry.  To determine whether tyrosine phosphorylation is required for reovirus 
uptake and endocytic transport, β1+/+ and β1+/+Y783F/Y795F cells should be pretreated 
with the tyrosine phosphorylation inhibitors, genistein (3) and herbimycin A (130), and 
infected with reovirus virions and ISVPs.  Viral entry should be analyzed by confocal 
microscopy and infection by indirect immunofluorescence (156).  Based on my 
preliminary results (data not shown), I expect that there will be a decrease in reovirus 
internalization in the presence of tyrosine phosphorylation inhibitors.  To determine 
whether β1 integrin is phosphorylated during reovirus entry, β1+/+ and 
β1+/+Y783F/Y795F cells should be incubated with [32P] orthophosphate, infected with 
virions and ISVPs, and lysed over a time course.  Lysates should be used for 
immunoprecipitation with a β1 integrin-specific antibody and subjected to SDS-PAGE 
(44).  These experiments will define whether tyrosine residues of β1 integrin NPXY 
motifs are phosphorylated during reovirus entry.  If tyrosine phosphorylation inhibitors 
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lead to a decrease in reovirus infection, or if β1 integrin is phosphorylated, experiments 
should be performed to test whether integrin-linked proteins expressed in focal adhesions, 
such as α-actinin (185) and talin (199), and signaling molecules, such as paxillin, FAK 
(222) and ILK (107) are activated during reovirus entry.  β1+/+ and β1+/+Y783F/Y795F 
cells should be infected, harvested over a time course, subjected to immunoprecipitation 
with a β1 integrin-specific antibody, resolved by SDS-PAGE, and immunoblotted with 
antibodies specific for α-actinin, talin, paxillin, FAK, or ILK.   
Alternatively, alteration of the β1 integrin NPXY motifs may affect reovirus 
infection indirectly.  The NPXY motifs are separated only by eight residues, and the 
structure of NPXY results in a β turn in solution (12, 252), which can serve as docking 
sites for PTBs (245).  Furthermore, integrin-associated proteins that bind to NPXY motifs 
including talin (42) and integrin cytoplasmic domain-associated protein (ICAP)1-α (50) 
may play a role in reovirus infection.  In addition, two of the eight intervening residues 
are threonines at positions 788 and 789, and T788 is essential for integrin-ligand 
engagement and activation (179).  Therefore, it is possible that mutation of the NPXY 
motifs results in structural constraints that affect the β1 cytoplasmic tail and therefore fail 
to support reovirus infection.   
Based on data presented in Chapter II (Fig. 14) and Chapter III (Fig. 19), it is 
possible that reovirus entry induces actin remodeling.  Many viruses stimulate actin 
remodeling to allow viral entry, transport, or egress from cells (65).  For example, 
vaccinia virus causes actin cytoskeleton rearrangement during entry and actin 
polymerization for cell-to-cell spread (63, 64).  Additionally, human cytomegalovirus, 
which utilizes α2β1 and α6β1 integrins to mediate viral entry (89), induces actin 
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depolymerization at 10-20 min post-infection, which is required for viral entry and 
infectivity (128).  These findings suggest that integrin-engaging viruses take advantage of 
the capacity of integrins to induce cytoskeletal rearrangement for viral internalization and 
infection of target cells.   
To determine whether actin remodeling is required for reovirus entry,  β1+/+ and 
β1+/+Y783F/Y795F cells should be treated with latrunculin A, which disrupts 
microfilament-mediated processes (172), and jasplakinolide, which stabilizes actin 
polymers (41), and analyzed for reovirus entry by confocal microscopy.  Preliminary data 
suggest that treatment of cells with latrunculin A leads to a decrease in reovirus 
infectivity as measured by EIA (data not shown).  Furthermore, to determine whether 
reovirus travels along the actin cytoskeleton to reach cellular endosomes, β1+/+ and 
β1+/+Y783F/Y795F cells should be transfected with a plasmid expressing EGFP-actin 
and infected with Alexa 546-labeled reovirus virions.  Reovirus entry should be 
monitored in real time by confocal microscopy.  Collectively, these studies should 
elucidate a requirement for β1-induced signaling and actin remodeling in reovirus entry 
and provide a better understanding of the role of β1 integrin in endocytosis.    
 
The Role of β1 Integrin in Reovirus Pathogenesis 
 Receptor engagement plays a key role in viral pathogenesis.  Differences in 
reovirus tropism in the CNS segregate with the σ1-encoding S1 gene segment (250, 260).  
However, differences in reovirus tropism cannot be fully explained by utilization of 
JAM-A, which is a serotype-independent receptor (43).  Furthermore, JAM-A-/- mice are 
susceptible to reovirus infection (Antar, A.A.R. and Dermody T.S., unpublished results).  
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The reovirus RGD- and KGE-motif containing λ2-encoding L2 gene segment has been 
linked to viral shedding and spread to littermates in pathogenesis studies in mice (134).  
Therefore, it is possible that integrins influence tissue tropism and disease outcome in 
reovirus-infected animals.  
 To test the function of β1 integrin in reovirus pathogenesis, the most logical 
approach would be to utilize β1 integrin knockout mice.  However, β1 integrin-null mice 
are not viable (237).  Instead, transgenic mice in which the β1 integrin NPXY motifs are 
mutated to NPXF are viable, fertile, and do not exhibit phenotypic abnormalities (66).  
Thus, these mice should be used to determine whether mutation of the β1 integrin NPXY 
motifs affects reovirus virulence and disease.  These experiments will test the hypothesis 
that β1 integrin NPXY-mediated recruitment of endocytic machinery and delivery of 
reovirus to the proper endocytic compartment in vivo can influence pathogenesis.   
 NPXY-to-F mice and wild-type mice should be infected with a wild-type LD50 
dose of reovirus, and intestine, brain, liver, lung, and spleen should be harvested at days 
4, 8, and 12 after peroral inoculation.  Tissues should be homogenized by sonication, and 
viral titers should be determined by plaque assay (256).  Titer in the intestine will indicate 
the extent of primary replication, while titer in other organs will reflect systemic spread 
and growth at secondary sites.  To determine kinetics of viral growth in the CNS, 
newborn mice should be inoculated intracranially with an LD50 dose of virus, and mice 
should be euthanized on days 2, 4, 6, and 8 post-infection.  Viral titers in brain-tissue 
homogenates should be determined by plaque assay.  These experiments will determine 
whether integrin expression is required for growth at a primary site of inoculation, 
systemic dissemination, or growth at a site of secondary replication.  I anticipate that β1 
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integrin utilization will affect reovirus pathogenesis, most likely at the level of tissue 
tropism.  It will be especially interesting to investigate whether β1 integrin influences 
tropism in the CNS.   
 The role of β1 integrin as the primary attachment and entry receptor in vivo 
should be investigated.  Similarities in reovirus and Yersinia pseudotuberculosis 
attachment and entry in cell culture and in vivo are remarkable.  Both reovirus and 
Yersinia utilize β1 integrin to mediate internalization into target cells (119, 156).  
Yersinia engages β1 integrin directly (253) when paired with multiple α subunits (119), 
which also is possible for reovirus.  Additionally, β1 integrin NPXY motifs mediate the 
AP-2-clathrin-dependent uptake mechanism of Yersinia (106, 254).  Reovirus and 
Yersinia both initially bind to intestinal M cells to initiate infection in mice (59, 215) and 
then transcytose to infect underlying Peyer’s patches (17, 214).  Binding and 
internalization of Yersinia into M cells is dependent on interactions of the binding protein 
invasin with β1 integrin (59).  By analogy to Yersinia, reovirus may initially engage β1 
integrin on the apical surface of M cells to mediate attachment and uptake into host cells.  
To test this possibility, mice should be infected with reovirus by peroral inoculation, and 
intestinal sections should be analyzed over a time course immediately following infection 
for both M cell-specific markers (59) and reovirus (170).  For these studies, wild-type and 
RGD- and KGE-mutant viruses should be used to further elucidate the role of reovirus-
integrin engagement in vivo.  This study would provide new information about the 
infectivity of reovirus in the intestinal lumen and may provide interesting insights into 
common mechanisms of infection by unrelated intestinal pathogens.   
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Conclusions 
 My thesis provides a framework to investigate mechanisms underlying reovirus 
internalization into target cells both in vitro and in vivo.  The future studies described in 
this chapter will enhance an understanding of how reovirus engages its internalization 
receptor on the cell surface.  Additionally, these studies will elucidate mechanisms of β1 
integrin-mediated endocytosis, and may uncover novel components of the β1 integrin 
endocytic pathway.  These studies also may identify signaling pathways elicited by β1 
integrin in response to reovirus.  This work will improve our understanding of 
nonenveloped virus cell entry and may serve as a platform for development of antiviral 
therapies that inhibit virus entry into target cells.  
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CHAPTER V 
 
MATERIALS AND METHODS 
 
Cells, Viruses, and Antibodies 
Spinner-adapted murine L929 (L) cells were grown in either suspension or 
monolayer cultures in Joklik’s modified Eagle’s minimal essential medium (Irvine 
Scientific, Santa Ana, CA) supplemented to contain 5% fetal bovine serum, 2 mM L-
glutamine, 100 U of penicillin per ml, 100 U of streptomycin per ml, and 0.25 mg 
amphotericin per ml (Gibco Invitrogen Corp., Grand Island, NY).  Chinese hamster ovary 
(CHO) cells were maintained in Ham’s F12 medium (Irvine Scientific) supplemented to 
contain 10% fetal bovine serum, 100 U of penicillin per ml, and 100 U of streptomycin 
per ml.  HeLa cells were maintained in Dulbecco’s minimal essential medium (Gibco 
Invitrogen Corp.) and supplemented as described for CHO cells.  Primary cultures of 
chick embryo fibroblasts (CEFs) were obtained from Paul Spearman (Vanderbilt 
University) and maintained in Medium 199 with Earle’s salts and 2.2 mg sodium 
bicarbonate per ml (Gibco Invitrogen Corp.) supplemented to contain 5% fetal bovine 
serum, 10% tryptose phosphate broth, 1% chicken serum (Gibco Invitrogen Corp.), and 
antibiotics as described for CHO cells.  GD25, GD25β1A GD25β1AY783F, 
GD25β1AY795F, and GD25β1AY783/F,Y795F cells were obtained from Deane Mosher 
(University of Wisconsin, Madison) (263) and maintained as described for HeLa cells.  
Medium for GD25β1A, GD25β1AY783F, GD25β1AY795F, and 
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GD25β1AY783F/Y795F cells was supplemented to contain 10 μg of puromycin (Sigma-
Aldrich, St. Louis, MO) per ml to maintain β1 integrin expression.  
Reovirus strains type 1 Lang (T1L) and type 3 Dearing (T3D) are laboratory 
stocks.  Working stocks of virus were prepared by plaque purification and passage in L 
cells (256).  Purified virions were generated from second-passage L-cell lysate virus 
stocks.  Virus was purified from infected cell lysates by freon extraction and CsCl 
gradient centrifugation as described (93).  Bands corresponding to the density of reovirus 
particles (1.36 g/cm3) were collected and dialyzed against virion storage buffer (150 mM 
NaCl, 15 mM MgCl2, 10 mM Tris-HCl [pH 7.4]).  Reovirus particle concentration was 
determined from the equivalence of 1 OD260 unit = 2.1 x 1012 particles (232).  Viral 
infectivity titers were determined by either plaque assay (256) or fluorescent focus assay 
(14).  ISVPs were generated by treatment of 2 x 1011 virion particles per ml with 2 mg of 
α-chymotrypsin (Sigma-Aldrich) per ml in a volume of 100 μl virion storage buffer at 
37°C for 30 min (11).  Reactions were terminated by the addition of 
phenylmethylsulphonylfluoride to a final concentration of 1.0 mM.  Purified T1L virions 
in carbonate-bicarbonate buffer (Sigma-Aldrich) were fluoresceinated by incubation in 
50 μg fluorescein (FITC) (Pierce, Rockford, IL) per ml at room temperature for 1 h (99).  
Excess FITC was removed by exhaustive dialysis against PBS. 
IgG fractions of rabbit antisera raised against T1L and T3D (264) were purified 
by protein A sepharose as previously described (14).  Fluorescently conjugated secondary 
Alexa antibodies were obtained from Molecular Probes (Invitrogen, San Diego, CA).  
The hJAM-A-specific monoclonal antibody (MAb) J10.4 and control mouse ascites were 
provided by Charles Parkos (Emory University School of Medicine) (150), and the 
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mJAM-A-specific MAb H202-106-7-4 was provided by Beat Imof (University of 
Geneva).  The human α2-specific MAb AA10 (IgM) (24) and human β1-specific MAb 
DE9 (IgG1) (24) were used as diluted ascites.  Human integrin-specific MAbs MAB1980 
(αv), MAB1973 (α1), MAB2057 (α3), MAB1378 (α6), MAB1976 (αvβ3), and 
MAB1961Z (αvβ5) were purchased from Chemicon International (Temecula, CA).  
Antibody BIIG2 (α5) (Developmental Hybridoma Studies Bank, University of Iowa, 
Iowa City, IA) was provided by John Williams (Vanderbilt University).  Function-
blocking human α2-specific MAb 6F1 was provided by Richard Bankert (State 
University of New York at Buffalo).  Function-blocking murine β1 MAb CD29 (IgM) 
and hamster IgM isotype control were purchased from BD Biosciences Pharmingen (San 
Jose, CA).  Murine β1-specific MAb MAB1997 (Chemicon) and human β1-specific 
MAb MAB2253Z (Chemicon) were used to assess expression of β1 integrin on GD25, 
GD25β1A, GD25β1AY783F, GD25β1AY795F, and GD25β1AY783F/Y795F cells and 
HeLa cells, respectively, by flow cytometry.  ICAM-1-specific MAb was purchased from 
Santa Cruz Biotechnology (Santa Cruz, CA).  Antibodies used for flow cytometric 
analysis of HeLa cells are shown in Table 1.  
 
Sequence Analysis 
Sequences of the reovirus λ2-encoding L2 gene from strains T1L (NC_004259), 
type 2 Jones (T2J) (NC_004260), T3D (NC_004275), T1Neth85 (AF378004), T2SV59 
(AF378006), T3C9 (AF378007), T3C18 (AF378008), T3C87 (AF378009), and T3C93 
(AF378010) were aligned using the protein sequence alignment algorithm in MacVector, 
version 8.0.1 (Accelrys, San Diego, CA). 
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 Plasmid Constructs 
 Human JAM-A was subcloned into expression plasmid pcDNA3.1+ (Invitrogen) 
(91).  Truncation mutant JAM-A-ΔCT was generated by PCR using full-length JAM-A 
cDNA as template.  Amino acids 1-260 (Δ261-299) were cloned and appended with a 
stop codon using T7 primer and 5’TACGGGATCCTCAGGCAAACCAGATGCC-3’ as 
forward and reverse primers, respectively.  The gene-specific primer encompasses 
nucleotides 981-995 of the JAM-A cDNA.  The PCR product was digested with BamHI 
(recognition site underlined in the reverse primer sequence) and subcloned into 
complementary restriction sites of pcDNA3.1+.  Fidelity of cloning was confirmed by 
automated sequencing.  Plasmid constructs encoding murine integrin αv (90) and α2 (83) 
were previously described.  A cDNA encoding murine β1 integrin cloned into the EcoR1 
site of pGEM1 was obtained from Richard Hynes (Massachusetts Institute of 
Technology) (D. W. DeSimone, V. Patel, and R. O. Hynes, unpublished).  Integrin 
cDNAs were subcloned into the expression plasmid pcDNA3.1+. 
 
Transfections 
Monolayers of cells in a 24-well plate (Costar, Cambridge, MA) were transfected 
with empty vector or plasmids encoding receptor constructs by using Lipofectamine 
PLUS reagent (Invitrogen).  Cells were incubated for 24 h to allow for receptor 
expression prior to adsorption with either reovirus virions or ISVPs for infectivity 
studies. 
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Flow Cytometric Analysis:  Expression and Binding 
Surface expression of integrin subunits and JAM-A was determined by flow 
cytometry.  Cells were detached from plates by using PBS-EDTA (20 mM EDTA).  Cells 
were washed and centrifuged at 2,000 x g to form a pellet, resuspended with integrin-
specific or control antibodies in PBS-BSA (Sigma-Aldrich) (5% BSA), and incubated at 
4°C for 1 h.  Cells were washed twice and incubated with an appropriate secondary 
antibody conjugated to R-phycoerythrin (PE) (BD Biosciences Pharmingen) at 4°C for 1 
h.  Cells were washed, resuspended in PBS, and analyzed by flow cytometry.  Results 
were analyzed using Windows Multiple Document 2.8 Flow Cytometry Application (The 
Scripps Research Institute, La Jolla, CA).  The fluorescence intensity was measured for 
an average of 14,000 gated events for cells treated with control antibodies, integrin-
specific, or JAM-A-specific antibodies.  Events were gated relative to cells stained with 
an appropriate secondary antibody conjugated to PE.   
Chapter II:  Reovirus binding to β1-/- and β1+/+ cells was analyzed by adsorbing cells 
with 2 x 1011 FITC-labeled particles of strain T1L at 4°C for 1 h.  Cells were washed and 
analyzed by flow cytometry. 
Chapter III:  Reovirus binding to GD25, GD25β1A, GD25β1AY783F, GD25β1AY785F, 
and GD25β1AY783F/Y795F cells was analyzed by adsorbing cells with 10,000 particles 
per cell of strain T1L at 4°C for 1 h.  Cells were washed and then stained with reovirus 
polyclonal antisera and an appropriate secondary antibody conjugated to PE (BD 
Biosciences Pharmingen) and analyzed by flow cytometry. 
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Fluorescent-Focus Assay of Viral Infection 
Cells were plated in 24-well or 96-well plates (Costar) and adsorbed with virus at 
various MOIs at either 4°C or room temperature for 30 to 60 min.  Inocula were 
removed, cells were washed, and complete medium was added.  Infected cells were 
incubated at 37°C for 16 to 24 h to allow a single cycle of viral replication.  Cells were 
fixed with methanol at -20°C for at least 30 min.  Fixed cells were incubated with PBS-
BSA (5% BSA) for at least 15 min, followed by incubation with reovirus-specific 
polyclonal antiserum (1:500) in PBS-Triton X-100 (0.5% TX-100) at room temperature 
for 1 h.  Cells were washed twice and incubated with an Alexa 488- or 546-labeled anti-
rabbit IgG (1:1000) in PBS-TX-100 (0.5% TX-100) at room temperature for 1 h.  Cells 
were washed twice and visualized by indirect immunofluorescence at a magnification of 
20X using Axiovert 200 fluorescence microscope (Carl Zeiss, New York, NY).  Infected 
cells (fluorescent focus units [FFU]) were identified by diffuse cytoplasmic fluorescence 
staining that was excluded from the nucleus.  Reovirus-infected cells were quantified by 
counting random fields of view of equivalently confluent monolayers for 3 to 5 fields of 
view for triplicate wells or by counting the entire well for triplicate wells (14). 
 
Confocal Imaging of Reovirus Internalization 
Cells were plated on coverslips in 24-well plates.  Chapter II: Cells were chilled at 
4°C for 45 min prior to infection, washed with PBS, adsorbed with 8 x 105 particles per 
cell of T1L virions in gelatin saline, and returned to 4°C for 1 h.  The MOI used was the 
minimum number of particles required to detect signal by confocal immunofluorescence 
microscopy at early time-points post-infection.  Chapter III:  Cells were untreated or pre-
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treated with 5µg/ml chlorpromazine (Alexis Biochemicals, San Diego, CA) for 3 h.  Cells 
were adsorbed with 5 x 104 particles per cell of T1L virions in incomplete medium at 4°C 
for 1 h.  Cells were either washed and fixed or non-adherent reovirus was aspirated and 
replaced with warm DMEM and returned to 37°C.  At 10-min intervals, cells were 
washed with PBS and fixed with 4% formaldehyde for 20 min.  Excess formaldehyde 
was quenched with an equal amount of 0.1 M glycine, followed by washing with PBS.  
Cells were treated with 1% TX-100 for 5 min and incubated with PBS-BGT (PBS, 0.5% 
BSA, 0.1% glycine, and 0.05% Tween-20) for 10 min.  Cells were incubated with 
reovirus-specific polyclonal antiserum (1:500) in PBS-BGT for 1 h and washed with 
PBS-BGT.  Cells were stained with donkey anti-rabbit immunoglobulin conjugated to 
Alexa Fluor 488 (Molecular Probes) (1:500) to visualize reovirus, phalloidin conjugated 
to Alexa Fluor 546 (Molecular Probes) (1:100) to visualize actin, and TO-PRO 3 
conjugated to Alexa Fluor 642 (Molecular Probes) (1:1000) to visualize DNA.  Cells 
were incubated for 1 h with secondary antibodies and fluorescent probes in PBS-BGT 
and washed with PBS-BGT.  Coverslips were removed from wells and placed on slides 
using Prolong Anti-Fade mounting media (Molecular Probes).  Images were captured on 
a Zeiss LSM 510 Laser-Scanning Confocal Microscope using LSM 510 software.   
Chapter II:  Virus internalization was quantitated by enumerating fluorescent particles 
localized at the cell periphery and particles internalized into the cytoplasm to determine 
the total number of fluorescent particles per cell.  Ten cells were analyzed for each time 
point.  The number of internalized particles was measured as a percentage of the total 
number of particles per cell.   
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Chapter III:  Viral internalization was quanitated as a function of pixel intensity using 
Metamorph software.  Confocal images were analyzed for reovirus particles by defining 
the intracellular space using the trace tool to exclude the plasma membrane, which was 
identified by intense actin staining.  The region measurement function was used to 
measure the intensity of the green pixels in the trace region.  Since cell size varies, the 
average pixel intensity was multiplied by the total area of the cell to determine the total 
pixel intensity per cell.   
 
Electron Microscopy 
 1x106 cells were plated in 60 mm dishes (Costar) and incubated overnight at 
37°C.  Medium was removed and cells were infected with reovirus strain T1L at an MOI 
of 1 x 105 particles per cell in incomplete medium or incubated in incomplete medium 
alone.  Virus was adsorbed at 4°C for 1 h to allow viral attachment.  Cells were washed 2 
times with PBS and then cells were harvested or complete medium was added and cells 
were incubated at 37°C for 10-min intervals for 30 min.  Cells were harvested on ice in 
1ml of PBS using a cell lifter (Costar), and transferred to a 1.5 ml microcentrifuge tube.  
Cells were pelleted at 2.5 x g for 5 min.  PBS was aspirated and 1ml of 2% 
gluteraldehyde was placed over the cell pellet.  Cells were incubated at room temperature 
for 45 min – 1.5 h.  Gluteraldehyde was then aspirated and replaced with fresh 2% 
gluteraldehyde for overnight incubation.  After overnight fixation samples were washed 
three times in PBS, transferred to 1% osmium textroxide in diH2O for 1h, and washed 
three times in diH2O.  Preparations were then stained en bloc in 1% aqueous uranyl 
acetate for 1 hr, washed three times in diH2O and dehydrated in a series of EtOH (30%-
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100%).  Samples were passed through propylene oxide, transferred to a 1:1 
araldite:propylene oxide mixture, and removed and embedded in Araldite embedding 
media.  Ultra-thin serial sections (50-60 nm) were obtained on a Leica UCT Ultracut 
microtome (Leica Microsystems, Vienna, Austria), transferred to formvar-coated grids, 
and examined on a Phillips CM10 TEM (FEI Company, Hillsboro, OR) equipped with an 
Advantage Plus Digital CCD System for CM10 TEM. (Advanced Microscopy 
Techniques, Danvers, MA).  Chemical supplies were purchased from Electron 
Microscopy Sciences (Fort Washington, PA).   
 
Early Infectivity Assay 
1x106 cells were plated in 60 mm dishes (Costar) and incubated overnight at 
37°C.  Cells were infected with 1 x 104 particles per cell of T1L virions in incomplete 
medium at 4°C for 1 h.  Cells were washed 3 times with PBS and then complete medium 
or media containing 200µM ribavirin (Sigma) was added and cells were incubated at 
37°C for 3.5 h.  Cells were harvested by scraping cells in 1 ml of PBS and then 
centrifuged at 3,000 x g to form a pellet.  PBS was aspirated and pellets were frozen.  
RNA was extracted using a RNeasy mini RNA extraction kit (Qiagen, Valencia, CA).  
Samples were subjected to RT-PCR using a one-step RT-PCR kit (Qiagen) with reovirus 
L1-specific primers 5’CTGCATCCATTGTAAATGACGAGTC 3’ and 5’ 
GCTATGTCATATTTCCATCCGAATTC  3’ (140, 141) and mouse β-actin-specific 
primers (Invitrogen).  RT-PCR reactions were resolved by agarose gel electrophoresis 
and stained using ethidium bromide.  For detailed protocol information see Appendix C.   
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Statistical Analysis 
Means of triplicate samples were compared by using an unpaired Students’ t-test 
(Microsoft Excel, Redmond, WA).  P values < 0.05 were considered to be statistically 
significant. 
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Reovirus infection is initiated by interactions between the attachment protein 1 and cell surface carbo-
hydrate and junctional adhesion molecule A (JAM-A). Expression of a JAM-A mutant lacking a cytoplasmic
tail in nonpermissive cells conferred full susceptibility to reovirus infection, suggesting that cell surface
molecules other than JAM-A mediate viral internalization following attachment. The presence of integrin-
binding sequences in reovirus outer capsid protein 2, which serves as the structural base for 1, suggests that
integrins mediate reovirus endocytosis. A 1 integrin-specific antibody, but not antibodies specific for other
integrin subunits, inhibited reovirus infection of HeLa cells. Expression of a 1 integrin cDNA, along with a
cDNA encoding JAM-A, in nonpermissive chicken embryo fibroblasts conferred susceptibility to reovirus
infection. Infectivity of reovirus was significantly reduced in 1-deficient mouse embryonic stem cells in
comparison to isogenic cells expressing 1. However, reovirus bound equivalently to cells that differed in levels
of 1 expression, suggesting that 1 integrins are involved in a postattachment entry step. Concordantly,
uptake of reovirus virions into 1-deficient cells was substantially diminished in comparison to viral uptake
into 1-expressing cells. These data provide evidence that 1 integrin facilitates reovirus internalization and
suggest that viral entry occurs by interactions of reovirus virions with independent attachment and entry
receptors on the cell surface.
Viral attachment and cell entry are key determinants of
target cell selection in the infected host and thus play impor-
tant roles in pathogenesis. Many viruses interact with multiple
cell surface molecules to mediate the processes of attachment
and internalization (68). For example, human immunodefi-
ciency virus uses CD4 to bind the cell surface and chemokine
receptors to facilitate the conformational alterations in enve-
lope glycoproteins that culminate in fusion of the viral enve-
lope and cell membrane (35). Receptors that serve as initial
binding sites have been identified for many viruses (25). How-
ever, little is known about the postattachment events that lead
to nonenveloped virus internalization, in particular those that
mediate virus uptake into the endocytic pathway.
Mammalian reoviruses are large, nonenveloped, double-
stranded RNA-containing viruses that infect a variety of mam-
malian species. Following attachment to target cells, reoviruses
are internalized by receptor-mediated endocytosis (3, 13, 14,
72), which is mostly likely to be clathrin dependent (31). Pro-
teolytic disassembly in endosomes leads to removal of outer
capsid protein 3 and cleavage of outer capsid protein 1 (3,
14, 27, 72). The resultant disassembly intermediate formed by
these events, the infectious subvirion particle (ISVP), is capa-
ble of penetrating endosomal membranes in a 1-dependent
manner to release the transcriptionally active viral core parti-
cle into the cytoplasm (17, 18, 58), where viral replication takes
place. Cellular determinants of reovirus receptor-mediated in-
ternalization following attachment and preceding uncoating
are poorly defined.
We previously identified junctional adhesion molecule A
(JAM-A) as a serotype-independent receptor for reovirus (5,
16, 34). JAM-A is a type 1 transmembrane protein expressed in
a variety of cell types, including polarized endothelial and
epithelial cells and circulating leukocytes (52, 55, 81). JAM-A
interacts with several scaffolding proteins and cytoplasmic
adaptor molecules (6, 28, 29) and is hypothesized to play an
important role in maintaining the barrier function of epithelial
junctions (48, 52, 55, 60). JAM-A is phosphorylated during
platelet activation and required for mitogen-activated protein
kinase activation following treatment of endothelial cells with
basic fibroblast growth factor (57). These data indicate that
JAM-A is intimately associated with cytoskeletal and signaling
machinery, which raises the possibility that reovirus binding
to JAM-A mediates cytoskeletal rearrangement or signaling
events to facilitate virus internalization.
The attachment mechanisms of reovirus and adenovirus are
remarkably similar (70, 71). The trimeric attachment proteins
of both viruses, 1 and fiber, respectively, are structural ho-
mologues and fold using a highly unusual triple -spiral motif
(10, 20, 83). The globular head domains of these molecules are
formed from eight-stranded -barrels with identical inter-
strand connectivity (70). The receptors for 1 and fiber,
JAM-A (5) and coxsackievirus and adenovirus receptor (CAR)
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(7), respectively, are two-domain, immunoglobulin superfamily
proteins that form homodimers using analogous molecular sur-
faces (71). Also, both JAM-A and CAR localize to tight junctions
in polarized epithelial cells (23, 52, 55, 60). Remarkably, reovirus
and adenovirus engage their respective receptors by thermody-
namically favored disruption of receptor homodimers (34, 53).
Despite mediating high-affinity attachment of adenovirus to
cells, engagement of CAR does not permit efficient adenovirus
internalization. Instead, adenovirus entry is enhanced by high-
avidity interactions of the viral penton base complex with in-
tegrins, including v3 and v5 (80). Integrins are hetero-
dimeric cell surface molecules that consist of  and  subunits
(43). Integrins function to mediate cellular adhesion to the
extracellular matrix, regulate cellular trafficking, and transduce
both outside-in and inside-out signaling events (42). In addi-
tion to adenovirus, several other pathogenic microorganisms
have usurped the adhesion and signaling properties of inte-
grins to bind or enter host cells (1, 8, 32, 39–41, 44, 49).
To define the molecular basis of reovirus internalization, we
first tested the capacity of a JAM-A mutant lacking a cytoplas-
mic tail to support reovirus attachment and infection. We
found that while JAM-A is necessary for efficient attachment
to cells, the JAM-A cytoplasmic tail is not required for reovirus
infection. Given the mechanistic conservation of reovirus and
adenovirus attachment strategies and the observation that re-
ovirus outer capsid protein 2 contains the conserved integrin-
binding sequences Arg-Gly-Asp (RGD) and Lys-Gly-Glu (KGE),
we tested the role of integrins in reovirus internalization. We
found that infection by reovirus virions is inhibited by antibod-
ies specific for 1 integrin. In addition, cells deficient in 1
integrin have a diminished susceptibility to reovirus infection
due to a postattachment block to viral entry. Together, these
data indicate that, following attachment to JAM-A, 1 integrin
facilitates internalization of reovirus into cells. Our findings
further demonstrate that two seemingly unrelated viruses uti-
lize distinct cellular molecules to mediate attachment and in-
ternalization in a remarkably similar manner.
MATERIALS AND METHODS
Cells, viruses, and antibodies. Spinner-adapted murine L929 (L) cells were
grown in either suspension or monolayer cultures in Joklik’s modified Eagle’s
minimal essential medium (Irvine Scientific, Santa Ana, CA) supplemented to
contain 5% fetal bovine serum, 2 mM L-glutamine, 100 U of penicillin per ml, 100
U of streptomycin per ml, and 0.25 mg amphotericin per ml (Gibco Invitrogen
Corp., Grand Island, NY). Chinese hamster ovary (CHO) cells were maintained
in Ham’s F12 medium (Irvine Scientific) supplemented to contain 10% fetal
bovine serum, 100 U of penicillin per ml, and 100 U of streptomycin per ml.
HeLa cells were maintained in Dulbecco’s modified Eagle’s medium (Gibco
Invitrogen Corp.) and supplemented as described for CHO cells. Primary cul-
tures of chicken embryo fibroblasts (CEFs) were obtained from Paul Spearman
(Vanderbilt University) and maintained in medium 199 with Earle’s salts and 2.2
mg sodium bicarbonate per ml (Gibco Invitrogen Corp.) supplemented to con-
tain 5% fetal bovine serum, 10% tryptose phosphate broth, 1% chicken serum
(Gibco Invitrogen Corp.), and antibiotics as described for CHO cells. GD25 and
GD251A cells were obtained from Deane Mosher (University of Wisconsin,
Madison) (78) and maintained as described for HeLa cells. Medium for
GD251A cells was supplemented to contain 10 g of puromycin (Sigma-Al-
drich, St. Louis, MO) per ml to maintain 1 integrin expression.
Reovirus strains type 1 Lang (T1L) and type 3 Dearing (T3D) are laboratory
stocks. Working stocks of virus were prepared by plaque purification and passage
in L cells (75). Purified virions were generated from second-passage L-cell lysate
virus stocks. Virus was purified from infected cell lysates by Freon extraction and
CsCl gradient centrifugation as described (36). Bands corresponding to the
density of reovirus particles (1.36 g/cm3) were collected and dialyzed against
virion storage buffer (150 mM NaCl, 15 mM MgCl2, 10 mM Tris-HCl [pH 7.4]).
Reovirus particle concentration was determined by the equivalence of 1 unit of
optical density at 260 nm to 2.1  1012 particles (69).
Viral infectivity titers were determined by either plaque assay (75) or fluores-
cent focus assay (4). ISVPs were generated by treatment of 2  1011 virion
particles per ml with 2 mg of -chymotrypsin (Sigma-Aldrich) per ml in a volume
of 100 l virion storage buffer at 37°C for 30 min (2). Reactions were terminated
by the addition of phenylmethylsulfonyl fluoride to a final concentration of 1.0
mM. Purified T1L virions in carbonate-bicarbonate buffer (Sigma-Aldrich) were
fluoresceinated by incubation with 50 g fluorescein isothiocyanate (FITC)
(Pierce, Rockford, IL) per ml at room temperature for 1 h (38). Excess FITC was
removed by exhaustive dialysis against phosphate-buffered saline (PBS).
Immunoglobulin G (IgG) fractions of rabbit antisera raised against T1L and
T3D (79) were purified by protein A-Sepharose as previously described (4).
Fluorescently conjugated secondary Alexa antibodies were obtained from Mo-
lecular Probes (Invitrogen, San Diego, CA). The human JAM-A (hJAM-A)-
specific monoclonal antibody (MAb) J10.4 and control mouse ascites were pro-
vided by Charles Parkos (Emory University School of Medicine) (52), and the
murine JAM-A (mJAM-A)-specific MAb H202-106-7-4 was provided by Beat
Imof (University of Geneva). The human 2-specific MAb AA10 (IgM) (8) and
human 1-specific MAb DE9 (IgG1) (8) were used as diluted ascites. Human
integrin-specific MAbs MAB1980 (v), MAB1973 (1), MAB2057 (3),
MAB1378 (6), MAB1976 (v3), and MAB1961Z (v5) were purchased from
Chemicon International (Temecula, CA). Antibody BIIG2 (5) (Developmental
Hybridoma Studies Bank, University of Iowa, Iowa City, IA) was provided by
John Williams (Vanderbilt University). Function-blocking human 2-specific
MAb 6F1 was provided by Richard Bankert (State University of New York at
Buffalo). Function-blocking murine 1 MAb CD29 (IgM) and hamster IgM
isotype control were purchased from BD Biosciences Pharmingen (San Jose,
CA). Murine 1-specific MAb MAB1997 (Chemicon) and human 1-specific
MAb MAB2253Z (Chemicon) were used to assess expression of 1 integrin on
GD25 and GD251A cells and HeLa cells, respectively, by flow cytometry.
ICAM-1-specific MAb was purchased from Santa Cruz Biotechnology (Santa
Cruz, CA). The antibodies used for flow cytometric analysis of HeLa cells are
shown in Table 1.
Sequence analysis. The sequences of the reovirus 2-encoding L2 gene from strains
T1L (NC_004259), type 2 Jones (T2J) (NC_004260), T3D (NC_004275), T1Neth85
(AF378004), T2SV59 (AF378006), T3C9 (AF378007), T3C18 (AF378008), T3C87
(AF378009), and T3C93 (AF378010) were aligned using the protein sequence align-
ment algorithm in MacVector, version 8.0.1 (Accelrys, San Diego, CA).
Plasmid constructs. Human JAM-A was subcloned into expression plasmid
pcDNA3.1 (Invitrogen) (34). Truncation mutant JAM-A-CT was generated
by PCR using full-length JAM-A cDNA as the template. Amino acids 1 to 260
(261–299) were cloned and appended with a stop codon using T7 primer and
5	-TACGGGATCCTCAGGCAAACCAGATGCC-3	 as the forward and re-
verse primers, respectively. The gene-specific primer encompasses nucleotides
981 to 995 of the JAM-A cDNA. The PCR product was digested with BamHI
(recognition site underlined in the reverse primer sequence) and subcloned into
the complementary restriction sites of pcDNA3.1. Fidelity of cloning was
confirmed by automated sequencing. Plasmid constructs encoding murine inte-
grin v (33) and 2 (30) were previously described. A cDNA encoding murine 1
integrin cloned into the EcoRI site of pGEM1 was obtained from Richard Hynes
(Massachusetts Institute of Technology) (D. W. DeSimone, V. Patel, and R. O.
TABLE 1. Surface expression of integrins on HeLa cells
Antibody Specificity Mean fluorescenceintensitya
MAB1997 (IgG control) Murine 1 integrin 2.65
MAB1973 Human 1 integrin 76.09
MAB6F1 Human 2 integrin 84.47
MAB2057 Human 3 integrin 73.31
MABBIIG2 Human 5 integrin 76.68
MAB1378 Human 6 integrin 81.86
MAB1980 Human v integrin 78.75
MAB2253Z Human 1 integrin 61.14
MAB1976 Human v3 integrin 5.46
MAB1961Z Human v5 integrin 42.10
a Results are expressed as mean fluorescence intensity for an average of 14,000
gated events as assessed by flow cytometry.
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Hynes, unpublished). Integrin cDNAs were subcloned into the expression plas-
mid pcDNA3.1.
Transient transfection of CHOs and CEFs. Monolayers of cells in a 24-well
plate (Costar, Cambridge, MA) were transfected with empty vector or plasmids
encoding receptor constructs by using Lipofectamine Plus reagent (Invitrogen).
Cells were incubated for 24 h to allow receptor expression prior to adsorption
with either reovirus virions or ISVPs for infectivity studies.
Flow cytometric analysis. Surface expression of integrin subunits on HeLa
cells was determined by flow cytometry. Cells were detached from plates by using
PBS-EDTA (20 mM EDTA). Cells were washed and centrifuged at 2,000  g to
form a pellet, resuspended with integrin-specific or control antibodies in PBS-
bovine serum albumin (BSA) (Sigma-Aldrich) (5% BSA), and incubated at 4°C
for 1 h. Cells were washed twice and incubated with an appropriate secondary
antibody conjugated to R-phycoerythrin (BD Biosciences Pharmingen) at 4°C
for 1 h. Cells were washed, resuspended in PBS, and analyzed by flow cytometry.
Results were analyzed using the Windows Multiple Document 2.8 flow cytometry
application (The Scripps Research Institute, La Jolla, CA).
The mean fluorescence intensity was measured for an average of 14,000 gated
events for cells treated with control or integrin-specific antibodies. Events were
gated relative to cells stained with an appropriate secondary antibody conjugated
to phycoerythrin. Reovirus binding to GD25 and GD251A cells was analyzed by
adsorbing cells with 2  1011 FITC-labeled particles of strain T1L at 4°C for 1 h.
Cells were washed and analyzed by flow cytometry.
Fluorescent focus assay of viral infection. Cells were plated in 24-well or
96-well plates (Costar) and adsorbed with virus at various multiplicities of infec-
tion (MOIs) at either 4°C or room temperature for 30 to 60 min. Inocula were
removed, cells were washed, and complete medium was added. Infected cells
were incubated at 37°C for 16 to 24 h to allow a single cycle of viral replication.
Cells were fixed with methanol at 
20°C for at least 30 min. Fixed cells were
incubated with PBS-BSA (5% BSA) for at least 15 min, followed by incubation
with reovirus-specific polyclonal antiserum (1:500) in PBS–Triton X-100 (0.5%
Triton X-100) at room temperature for 1 h. Cells were washed twice and incu-
bated with an Alexa 488- or 546-labeled anti-rabbit IgG (1:1,000) in PBS-Triton
X-100 (0.5% Triton X-100) at room temperature for 1 h.
Cells were washed twice and visualized by indirect immunofluorescence at a
magnification of 20 using an Axiovert 200 fluorescence microscope (Carl Zeiss,
New York, NY). Infected cells (fluorescent focus units [FFU]) were identified by
diffuse cytoplasmic fluorescence staining that was excluded from the nucleus.
Reovirus-infected cells were quantified by counting random fields of view of
equivalently confluent monolayers for three to five fields of view for triplicate
wells or by counting the entire well for triplicate wells (4).
Confocal imaging of reovirus internalization. GD25 and GD251A cells were
plated on coverslips in 24-well plates. Cells were chilled at 4°C for 45 min prior
to infection, washed with PBS, adsorbed with 8  105 particles per cell of T1L
virions in gelatin saline, and returned to 4°C for 1 h. The MOI used was the
minimum number of particles required to detect signal by confocal immunoflu-
orescence microscopy at early time points postinfection. Cells were either
washed and fixed or nonadherent reovirus was aspirated and replaced with warm
Dulbecco’s modified Eagle’s medium and returned to 37°C. At 10-min intervals,
cells were washed with PBS and fixed with 4% formaldehyde for 20 min. Excess
formaldehyde was quenched with an equal amount of 0.1 M glycine, followed by
washing with PBS. Cells were treated with 1% Triton X-100 for 5 min and
incubated with PBS-BGT (PBS, 0.5% BSA, 0.1% glycine, and 0.05% Tween 20)
for 10 min. Cells were incubated with reovirus-specific polyclonal antiserum
(1:500) in PBS-BGT for 1 h and washed with PBS-BGT. Cells were stained with
donkey anti-rabbit immunoglobulin conjugated to Alexa Fluor 488 (Molecular
Probes) (1:500) to visualize reovirus, phalloidin conjugated to Alexa Fluor 546
(Molecular Probes) (1:100) to visualize actin, and TO-PRO 3 conjugated to
Alexa Fluor 642 (Molecular Probes) (1:1,000) to visualize DNA. Cells were
incubated for 1 h with secondary antibodies and fluorescent probes in PBS-BGT
and washed with PBS-BGT. Coverslips were removed from wells and placed on
slides using Prolong Anti-Fade mounting medium (Molecular Probes). Images
were captured on a Zeiss LSM 510 laser-scanning confocal microscope using
LSM 510 software.
Virus internalization was quantified by enumerating fluorescent particles lo-
calized at the cell periphery and particles internalized into the cytoplasm to
determine the total number of fluorescent particles per cell. Ten cells were
analyzed for each time point. The number of internalized particles was measured
as a percentage of the total number of particles per cell.
Statistical analysis. Means of triplicate samples were compared by using an
unpaired Students’ t test (Microsoft Excel, Redmond, WA). P values of 0.05
were considered statistically significant.
RESULTS
The JAM-A cytoplasmic tail is dispensable for reovirus in-
fection. JAM-A is a serotype-independent reovirus receptor
with a cytoplasmic tail known to interact with a variety of
proteins (6, 28, 29). To determine whether the JAM-A cyto-
plasmic tail is required for reovirus entry, we generated a
JAM-A cytoplasmic tail deletion mutant (JAM-A-CT) and
tested its capacity to support reovirus infection following trans-
fection of CHO cells. CHO cells do not express detectable
levels of JAM-A (55, 60) and are poorly permissive for reovirus
infection (34). Cells were transiently transfected with plasmids
encoding full-length JAM-A, JAM-A-CT, or empty vector as
a control. Equivalent cell surface expression of transfected
constructs was confirmed by flow cytometry (data not shown).
The capacity of reovirus to infect CHO cells following trans-
fection with the JAM-A constructs was tested using reovirus
fluorescent focus assays. Following transient transfection of
CHO cells with empty vector, JAM-A, or JAM-A-CT, cells
were adsorbed with reovirus strains T1L and T3D and scored
for infection by indirect immunofluorescence at 20 h postin-
fection (Fig. 1). Expression of either full-length or truncated
FIG. 1. JAM-A cytoplasmic tail is not required for reovirus infec-
tion. CHO cells were transiently transfected with empty vector or
plasmids encoding JAM-A or JAM-A-CT. Following incubation for
24 h to permit receptor expression, cells were adsorbed with reovirus
strains T1L (A) or T3D (B) at an MOI of 0.1 FFU per cell at room
temperature for 1 h. Cells were washed with PBS, incubated in com-
plete medium at 37°C for 20 h, and stained by indirect immunofluo-
rescence. Infected cells were quantified by counting cells exhibiting
cytoplasmic staining in entire wells for triplicate experiments. The
results are expressed as the mean FFU per well for triplicate samples.
Error bars indicate standard deviations. CHO cells support a low level
of infection by type 3 reovirus in the absence of JAM-A, likely attrib-
utable to the expression of sialic acid (16, 34).
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JAM-A was sufficient to allow reovirus infection of CHO cells,
permitting viral protein production of both type 1 and type 3
reovirus strains. These results indicate that the JAM-A cyto-
plasmic tail is not required for efficient reovirus attachment
and infection.
Reovirus outer capsid proteins contain integrin-binding se-
quences. Structural and functional analyses indicate that reo-
virus and adenovirus share remarkably similar mechanisms of
attachment (70, 71). To determine whether reovirus outer cap-
sid proteins contain sequences that could potentially engage
integrins, we performed a search for integrin-binding motifs in
the 1, 3, 1, and 2 proteins, which form the reovirus outer
capsid (26). We identified two common integrin-binding mo-
tifs, RGD and KGE, in the deduced amino acid sequence of
the 2 protein (Fig. 2). The RGD motif is conserved in all
reovirus strains for which sequence information is available
(15, 67); the KGE motif is conserved in all of those strains
except T2J (15, 67). The 2 protein is a component of the
reovirus outer capsid and core (26). It is structurally arranged
as a pentamer at the virion fivefold axes of symmetry and forms
the base for attachment protein 1 (26, 63). The presence of
conserved integrin-binding motifs in the reovirus 2 protein
led us to test whether reovirus utilizes integrins to mediate
internalization.
An antibody specific for 1 integrin inhibits reovirus infec-
tion of HeLa cells. To determine whether integrins are re-
quired for reovirus infection, we first used flow cytometry to
analyze integrin expression on the surface of HeLa cells. HeLa
cells were incubated with integrin-specific MAbs and a phyco-
erythrin-labeled secondary antibody (Table 1). RGD-binding
integrin subunits 3, 5, v, and 1 and KGE-binding integrin
subunits 1, 2, 6, and 1 (43) were detected on HeLa cells
at levels above those in control antibody-treated cells. RGD-
binding integrin heterodimer v5 also was detected at levels
above that of the control, while there was low-level expression
of v3. Thus, HeLa cells express both RGD- and KGE-
binding integrins.
To assess a role for integrins in reovirus replication, we
tested antibodies specific for the RGD- and KGE-binding in-
tegrins expressed on HeLa cells for the capacity to block reo-
virus infection. HeLa cells were incubated with integrin-spe-
cific and control antibodies prior to adsorption with reovirus
virions. Viral infection was detected by indirect immunofluo-
rescence (Fig. 3A). We found that 1-specific MAb DE9 re-
sulted in a 50% reduction in infection (P  0.05), while anti-
bodies specific for the other integrin subunits expressed on
HeLa cells had no effect. Control antibodies produced antici-
pated effects; JAM-A-specific MAb J10.4 inhibited infection,
whereas ICAM-specific MAb (data not shown) or control
mouse ascites (Fig. 3A) did not. The effect of MAb DE9 was
dose dependent (Fig. 3B), providing further evidence that the
inhibition of infection was dependent on integrin blockade.
To determine whether particular  subunits pair with 1
integrin to facilitate reovirus infection, we tested whether
treatment with  integrin-specific antibodies was capable of
enhancing the inhibitory effect of 1 integrin-specific MAb
DE9 on reovirus infection. We also tested whether antibodies
specific for other  integrin subunits expressed on HeLa cells,
3 and 5, were capable of infection blockade. HeLa cells were
treated with MAb DE9 in combination with other integrin-
specific antibodies prior to adsorption with reovirus virions
(Fig. 3C). While treatment of HeLa cells with MAb DE9
resulted in a 50% reduction in reovirus infection, none of the
other integrin-specific antibodies tested reduced reovirus in-
fection to a greater extent than that resulting from treatment
with DE9 alone. These results suggest that the integrin epitope
bound by reovirus is blocked by 1-specific MAb DE9 and not
by the other MAbs used in these experiments.
JAM-A MAb J10.4 blocks reovirus infection 90% (Fig.
3A). To determine whether the residual level of infection in
the presence of MAb J10.4 was dependent on reovirus inter-
actions with 1 integrin, we treated HeLa cells with JAM-A-
specific MAb J10.4 in combination with MAb DE9 prior to
adsorption with reovirus virions (Fig. 3D). Treatment of HeLa
cells with MAb J10.4 and MAb DE9 completely abrogated
reovirus infection, indicating that the effect of JAM-A block-
ade is enhanced when 1 integrin is not available for interac-
tions with reovirus. Treatment with MAb DE9 did not signif-
icantly inhibit infection by ISVPs (Fig. 3D), suggesting that
viral attachment is not affected by 1 integrin blockade. Taken
together, these results support the conclusion that a 1-specific
antibody blocks reovirus infection at a step subsequent to at-
tachment but prior to uncoating, implicating 1 integrin in
reovirus internalization.
Transient transfection of integrin cDNAs allows reovirus
infection of JAM-A-expressing CEFs. Ectopic expression of
JAM-A in CEFs rescues infection by reovirus ISVPs but not by
virions (5), suggesting that these cells exhibit a cell-specific
block at the entry or uncoating phases of reovirus infection. To
test the capacity of integrins to confer infection of CEFs by
reovirus virions, CEFs were transiently transfected with a
JAM-A-encoding plasmid in the presence or absence of mu-
rine v, 2, or 1 integrin-encoding plasmids singly or in 
pairs. Transfected cells were infected with reovirus virions or
ISVPs, and infection was assessed by indirect immunofluores-
FIG. 2. Reovirus outer capsid protein 2 contains integrin-binding
sequences. Alignment of deduced amino acid sequences of the reovi-
rus 2 protein for the indicated strains. Amino acid residues are des-
ignated by the single-letter code. Amino acid positions are indicated
above the first and last letters. Integrin-binding RGD (A) and KGE
(B) motifs are highlighted by a black box. Nonconserved sequences are
shown in unshaded boxes. CON, consensus sequence.
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cence (Fig. 4). Expression of 1 integrin paired with either of
the murine  integrin subunits provided an approximately
fourfold enhancement of infection by reovirus virions in com-
parison to that in cells transfected with JAM-A alone. These
data suggest that 1 integrin expression complements a reovi-
rus cell entry defect in CEFs and provide further support for
the involvement of 1 integrin in reovirus internalization.
Cells deficient in 1 integrin have a decreased capacity to
support reovirus infection. To further assess a role for 1
integrin in reovirus infection, we tested the capacity of reovirus
to infect cells deficient in the 1-integrin subunit. GD25 cells
are murine embryonic stem cells derived from 1-null embryos
(78). GD251A cells are GD25 cells that have been engi-
neered to stably express 1 integrin and thus serve as an
isogenic control for GD25 cells. Flow cytometric analysis con-
firmed that while both cells express JAM-A, only GD251A
cells express 1 integrin (Fig. 5A). GD25 cells (1
/
) and
GD251A cells (1/) (78) were adsorbed with reovirus viri-
ons or ISVPs, and infection was scored by indirect immuno-
fluorescence (Fig. 5B). In comparison to 1/ cells, 1
/

cells were substantially less susceptible to infection by virions,
while infection by ISVPs was equivalent in both cell types.
Importantly, preincubation of 1/ cells with murine 1 in-
tegrin-specific MAb CD29 reduced infection in 1/ cells
(Fig. 5C), indicating that enhancement of infection is due to
expression of 1 integrin. Therefore, 1 integrin is required for
efficient reovirus infection.
Reovirus binding to 1/ and 1/ cells is equivalent.
Equivalent infection of 1
/
 and 1/ cells by ISVPs (Fig.
5B) suggests that reovirus is capable of efficiently binding to
both cell types. To directly test this hypothesis, 1
/
 and
1/ cells were mock treated or incubated with FITC-labeled
virions and binding was assessed by flow cytometry (Fig. 6). In
these experiments, we found that reovirus binds equivalently to
1
/
 and 1/ cells. These data demonstrate a function for
FIG. 3. 1 integrin antibody reduces reovirus infection of HeLa cells.
HeLa cells were treated with gel saline (GS), control ascites (C), JAM-
A-specific MAb J10.4, or antibodies specific for the  and  integrins
shown (20 g per ml or as diluted ascites) (A), gel saline, control ascites
(Control), 2-specific MAb AA10, or 1-specific MAb DE9 (at the indi-
cated dilutions) (B), antibodies specific for the  and  integrins shown in
the presence of 1-specific MAb DE9 (1:10) (C), control ascites, 1-
specific MAb DE9, JAM-A-specific MAb J10.4, or JAM-A-specific MAb
J10.4 in combination with 1-specific MAb DE9 (D), and incubated at
room temperature for 1 h. Antibody-treated cells were infected with
virions or ISVPs of T1L at an MOI of 0.1 FFU per cell at 4°C for 30 min.
Cells were washed with PBS, incubated in complete medium at 37°C for
16 h, and stained by indirect immunofluorescence. Infected cells were
quantified by counting cells exhibiting cytoplasmic staining in three fields
of view for triplicate samples. The results are expressed as the mean FFU
per field for triplicate experiments. Error bars indicate standard devia-
tions. , P 0.05 in comparison to the control; , P 0.05 in comparison
to HeLa cells treated with JAM-A-specific MAb J10.4 alone.
FIG. 4. 1 integrin expression enhances reovirus infection of CEFs.
CEFs were transiently transfected with JAM-A-encoding plasmid
alone (vector) or in combination with plasmids encoding the integrin
subunits shown. Following 24 h to allow receptor expression, trans-
fected cells were adsorbed with T1L virions or ISVPs at an MOI of 1
FFU per cell at room temperature for 1 h. Cells were washed with
PBS, incubated in complete medium at 37°C for 20 h, and stained by
indirect immunofluorescence. Infected cells were quantified by count-
ing cells exhibiting cytoplasmic staining in entire wells for duplicate
samples. The results are expressed as the mean FFU per well for
duplicate experiments. Error bars indicate the range of data. Shown is
a representative experiment of three independent experiments per-
formed.
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1 integrin in reovirus infection at a step subsequent to viral
attachment.
1 integrin enhances the efficiency of reovirus internaliza-
tion. To directly assess the role of 1 integrin in reovirus
internalization, 1
/
 and 1/ cells were infected at 4°C and
then warmed to 37°C over a time course concurrent with reo-
virus entry (2, 72). At 10-min intervals, cells were fixed, stained
for indirect immunofluorescence, and examined by confocal
microscopy. Representative confocal micrographic images of
reovirus-infected 1
/
 and 1/ cells are shown in Fig. 7.
Immediately after viral adsorption, both cell types exhibited
reovirus staining at the cell periphery. At 10 min postadsorp-
tion, some reovirus staining was observed at the cell periphery,
yet intracellular staining in 1/ cells was also observed. At
20 and 30 min postadsorption, the majority of virions had
entered the 1/ cells and had a perinuclear location. In
sharp contrast to the findings made using 1/ cells, viral
entry was markedly delayed in 1
/
 cells, with the majority of
reovirus virions remaining at the cell periphery throughout the
time course. At later time points (30 min postadsorption),
some virions were present within the cytoplasm, but these were
the minority. These findings suggest that expression of 1
integrin enhances reovirus entry.
To quantify reovirus internalization into 1
/
 and 1/
cells, we determined the number of internalized fluorescent
particles as a percentage of the total number of fluorescent
particles per cell at various times postadsorption (Fig. 8). At 0
and 10 min postadsorption, the percentage of particles inter-
nalized into 1
/
 and 1/ cells was equivalent, 10 and
30%, respectively. However, at 20 and 30 min postadsorp-
tion, the percentage of reovirus particles internalized into
1/ cells was 50%, while the percentage of particles inter-
nalized into 1
/
 cells was only 30% (P  0.05) (Fig. 8).
These data indicate that 1 integrin enhances reovirus entry at
early times postadsorption, suggesting a direct role for 1
integrin as a reovirus internalization receptor.
DISCUSSION
In this study, we performed experiments to define the molec-
ular determinants of reovirus internalization. We show that anti-
bodies specific for 1 integrin inhibit reovirus infection at a
postattachment step. We provide evidence that expression of 1
integrin promotes infection by reovirus virions in cells with a
block to viral internalization and that viral entry is substantially
FIG. 5. Cells deficient in 1 integrin are less permissive for reovirus
infection. (A) GD25 (1
/
) and GD251A (1/) cells were de-
tached from plates with 20 mM EDTA, washed, and incubated with
antibodies specific for either murine 1 integrin or murine JAM-A.
Cell surface expression of these molecules was detected by flow cy-
tometry. Data are expressed as fluorescence intensity. GD25 and
GD251A cells were untreated (B) or pretreated with 1-specific
MAb CD29 (1 Ab) or a hamster isotype-matched control MAb (IgG)
at room temperature for 1 h (C), adsorbed with virions or ISVPs of
T1L at an MOI of 0.1 FFU per cell, and incubated at 4°C for 30 min.
Cells were washed with PBS, incubated in complete medium at 37°C
for 20 h, and stained by indirect immunofluorescence. Infected cells
were quantified by counting cells exhibiting cytoplasmic staining in five
fields of view for duplicate samples. The results are expressed as the
mean FFU per field for triplicate experiments. , P  0.05 in compar-
ison to the control.
FIG. 6. Reovirus exhibits equivalent binding to 1
/
 and 1/
cells. GD25 (1
/
) and GD251A (1/) cells were incubated with
either PBS (mock) or 2  1011 FITC-labeled T1L virions at 4°C for 1 h
and analyzed by flow cytometry to assess reovirus binding to the cell
surface. The results are expressed as fluorescence intensity.
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diminished in cells deficient in 1 integrin expression. Together,
these data provide strong evidence that 1 integrin serves as a
coreceptor to mediate reovirus internalization. These findings
suggest a new model for attachment and cell entry of reovirus
(Fig. 9). In this model, we propose that reovirus initially interacts
with cells via low-affinity binding to carbohydrate. These interac-
tions are followed by high-affinity engagement of JAM-A, which
positions the virus on the cell surface for subsequent interactions
with 1 integrin to trigger viral endocytosis.
Integrins have been identified as attachment and entry re-
ceptors for several viruses, including echovirus (21) (8),
foot-and-mouth disease virus (v1, v3, and v6) (9, 44,
45), hantaviruses NY-1 and Sin Nombre virus (3 integrins)
(37), Kaposi sarcoma herpesvirus (31) (1), and cytomegalo-
virus (21, 61, and v3) (32). The Reoviridae family
member rotavirus also engages a variety of integrins for at-
tachment and cell entry. Rotavirus strains RRV, SA11, and Wa
bind to the I (inserted) domain of 21 integrin via an Asp-
Gly-Glu integrin-binding motif in the VP4 spike protein to
effect viral attachment (39). The interactions of rotavirus outer
capsid protein VP7 with integrins x2 and v3 can mediate
viral entry (39, 82). Integrin 41 also can serve as a receptor
for rotavirus strain SA11, which contains 41 integrin-bind-
ing sequences Leu-Asp-Val in VP7 and Ile-Asp-Ala in VP4
FIG. 7. 1 integrin enhances reovirus entry into cells. (A) GD251A (1/) and (B) GD25 (1
/
) cells were chilled, adsorbed with T1L
virions, and incubated at 4°C for 1 h. Nonadherent virus was removed, warm medium was added, and cells were incubated at 37°C for the times
shown. Cells were fixed, stained for reovirus (green), actin (red), and DNA (blue), and imaged using confocal immunofluorescence microscopy.
Representative digital fluorescence images of the same field are shown in each row.
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(41). Interestingly, like reovirus, adenovirus engages a specific
cell surface protein, CAR, prior to interactions with integrins,
which function subsequent to viral attachment to mediate viral
endocytosis (50, 80). Therefore, the identification of 1 inte-
grin as a reovirus internalization receptor suggests that the
conservation of attachment strategies used by reovirus and
adenovirus (70, 71) extends to mechanisms of internalization.
Although the specific reovirus protein required for integrin
binding is not apparent from our studies, the 2 protein is a
promising candidate. The 2 protein forms a pentameric turret
at the virion fivefold symmetry axes and serves as the insertion
site for trimers of attachment protein 1 (26). Thus, 2 is the
reovirus analogue of the adenovirus penton base protein,
which mediates the engagement of integrins by adenovirus (22,
80). Interestingly, 2 also contains conserved RGD and KGE
motifs (15), the preferred interaction motifs for several 1
integrin heterodimers (43).
Structural information for 2 is available in the context of
the reovirus core but not for the intact virion. In the core, the
KGE motif is exposed on the top of the 2 turret, where it
would be accessible to a receptor. The RGD motif is also
surface exposed, but it appears to be less accessible. However,
the 2 structure in the core may not be identical to that in the
virion, as the protein undergoes major conformational changes
during virion-to-core disassembly (26). Therefore, it is possible
that both the RGD and KGE motifs are accessible to interac-
tions with 1 integrin during engagement of the cell surface by
the virus.
FIG. 7—Continued.
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A human 1 integrin-specific antibody (DE9) reduced reo-
virus infection of HeLa cells by 50% (Fig. 3). Similarly, a
murine 1 integrin-specific antibody (CD29) blocked infection
of 1-expressing mouse embryonic stem cells by 50% (Fig.
4). Interestingly, MAb DE9 also blocks infection of echovirus
(8) and cytomegalovirus (32), suggesting that an epitope in 1
integrin recognized by MAb DE9 may be a preferred binding
site for multiple viruses. It is possible that the residual level of
reovirus infection following 1 integrin antibody treatment is
attributable to other internalization receptors on the cell sur-
face that may be integrin or nonintegrin molecules. However,
it is noteworthy that treatment of HeLa cells with both MAb
DE9 and JAM-A-specific MAb J10.4 completely abolishes reo-
virus growth (Fig. 3D). This finding suggests that the residual
infection in J10.4-treated HeLa cells is due to reovirus inter-
actions with 1 integrin. Thus, it appears that blockade of
reovirus infection by integrin-specific antibodies is inefficient
because complete inhibition of virus-integrin interactions is
not possible if the virus is tightly adhered to the cell surface by
JAM-A.
Since antibodies specific for 3 and 5 integrins did not
inhibit reovirus infection, it is likely that only 1 integrin can
serve a reovirus internalization function. Antibodies specific
for the  integrin subunits expressed on HeLa cells did not
further reduce reovirus infection following treatment with a 1
integrin-specific antibody (Fig. 3C). We envision three possible
explanations for this result. First, reovirus may directly engage
a ligand-binding domain of 1 integrin. Second, reovirus may
utilize 1 integrin when paired with numerous  subunits that
have redundant functions. However, treatment of HeLa cells
with a 1 integrin-specific antibody and a mixture of antibodies
specific for 1, 2, 3, 5, 6, and v integrins did not diminish
reovirus infection in comparison to cells treated with a 1
integrin-specific antibody alone (data not shown). Third, reo-
virus may engage an epitope of an integrin  subunit that is not
recognized by the antibodies used in our experiments. Further
studies are required to define the biophysical basis of reovirus-
integrin interactions.
JAM-A is required for high-affinity reovirus attachment to
numerous cell types (5, 16, 34, 56). However, the JAM-A
cytoplasmic tail is not necessary for viral endocytosis (Fig. 1).
JAM-A likely tethers the virus to the cell surface to facilitate
secondary interactions with 1 integrin (Fig. 9). This model is
analogous to the mechanism of lymphocyte homing, in which
adhesion molecules such as JAM-A provide initial cellular
contacts to facilitate subsequent interactions with integrins for
diapedesis or signaling (65). An interesting possibility is that
JAM-A may be associated with 1 integrin on the host cell
plasma membrane. If such were the case, initial JAM-A en-
gagement might facilitate integrin binding, clustering, and viral
endocytosis. In support of this hypothesis, JAM-A has been
shown to regulate 1 integrin expression and localization (54).
The cytoplasmic domains of integrin subunits are involved in
a number of signaling pathways (42). The 1 integrin cytoplas-
mic domain is linked to cytoskeletal proteins, including talin
(62) and -actinin (59), and signaling molecules, including
paxillin and focal adhesion kinase (66). In addition, the 1
integrin cytoplasmic domain contains two Asn-Pro-any resi-
due-Tyr (NPXY) motifs (64), which are common sequence
motifs in the cytoplasmic domains of many receptors and serve
as recognition sites for the cellular endocytic machinery (21,
24). NPXY motifs interact with the 2 subunit of the adaptor
protein 2 complex (12, 61), which can recruit clathrin and
trigger clathrin-mediated endocytosis (47).
Since clathrin-dependent mechanisms have been implicated
in reovirus cell entry (31), it seems plausible that reovirus
engagement of 1 integrin leads to clathrin-mediated endocy-
tosis through signaling regulated by the 1 integrin cytoplasmic
domain. It is noteworthy that Kaposi’s sarcoma-related her-
pesvirus binding to 31 integrin (1) and cytomegalovirus
binding to 1 integrin (32) activate focal adhesion kinase. In
addition, adenovirus engagement of v integrins induces acti-
vation of phosphoinositide-3-OH kinase, which is required for
adenovirus endocytosis (51).
Identification of 1 integrin as a receptor that triggers reo-
virus entry raises the possibility that coreceptor binding influ-
ences reovirus tropism and disease. Reovirus serotypes differ
in mechanisms of spread, tropism for cells in the central ner-
vous system, and disease outcome in the infected host (73).
FIG. 9. Receptors for reovirus attachment and cell entry. Reovirus
initially engages cells by low-affinity interactions with carbohydrate.
For type 3 reovirus strains, this carbohydrate is sialic acid. Reovirus-
carbohydrate interactions are followed by high-affinity binding to
JAM-A, which positions the virus on the cell surface for subsequent
interactions with 1 integrin to trigger viral endocytosis.
FIG. 8. Quantification of reovirus internalization into 1
/
 and
1/ cells. Viral internalization was quantitated by enumerating fluo-
rescent particles localized at the cell periphery and particles internal-
ized into the cytoplasm to determine the total number of fluorescent
particles per cell. The results are expressed as mean percent internal-
ization (internalized fluorescent particles/total number of fluorescent
particles per cell) for 10 cells for each time point. , P  0.05 in
comparison to 1/ cells.
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Previous studies using reassortant genetics and comparative
sequence analysis demonstrated that these phenotypes segre-
gate most strongly with viral attachment protein 1, suggesting
that reovirus serotypes bind to different receptors (74, 76, 77).
However, the 1-encoding S1 gene is not the sole determinant
of reovirus growth at some sites within the host. For example,
the 2-encoding L2 gene influences viral growth in the intes-
tine (11) and spread to new hosts (46). Moreover, JAM-A
functions as a receptor for all three reovirus serotypes (16);
therefore, JAM-A cannot explain serotype-dependent differ-
ences in reovirus pathogenesis. The presence or absence of
particular integrins at distinct physiologic sites may critically
influence the course of reovirus infection. In support of a role
for coreceptor utilization in reovirus growth, reovirus infection
can occur in the absence of 1 (19) or JAM-A (5), albeit at
greatly reduced efficiency. These findings highlight the com-
plex nature of reovirus attachment and entry and suggest that
reovirus tropism and pathogenesis are not dictated by primary
receptor interactions alone. It is possible that tropism and
pathogenesis are determined by the concerted action of attach-
ment and internalization receptors, perhaps not all of which
have been discovered.
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Introduction 
 
Virus-receptor interactions are essential for initiation of viral infection, yet the 
significance of these events in reovirus pathogenesis is not known.  Type 1 and type 3 
reovirus strains exhibit striking differences in viral tropism in the CNS (260).  These 
phenotypic differences segregate with the σ1-encoding S1 gene segment, suggesting an 
important function for receptor engagement in tropism determination (250, 260).  
However, these differences cannot be explained by differential receptor engagement 
alone, as the only known σ1 head receptor, JAM-A, is a serotype-independent receptor 
(43).  Furthermore, reovirus pathogenesis is not solely determined by the S1 gene.  The 
reovirus λ2-encoding L2 gene segment segregates with viral shedding and spread to 
littermates (134).  Since integrin-binding motifs RGD and KGE are expressed in the 
reovirus λ2 protein (37, 156), it is possible that integrin-based components of the cell 
entry apparatus cooperate with JAM-A to influence tissue tropism and disease outcome.   
 Preliminary evidence from our laboratory suggested that α2β1 integrin is 
involved in reovirus infection.  An α2-specific MAb, AA10 (24), diminished reovirus 
infection in some experiments (data not shown).  Additional evidence suggested that 
reovirus binds directly to the α2 I domain of a glutathione-S-transferase (GST)-α2 I 
domain construct by enzyme-linked immunosorbent assay (ELISA) (data not shown).  I 
sought to determine whether integrins influence reovirus pathogenesis in vivo.  β1 
integrin KO mice are embryonically lethal (237).  However, α2-null mice are viable, 
fertile, and do not exhibit phenotypic abnormalities (54).  α2-null mice were made 
available to our laboratory by Dr. Mary Zutter.  The goal of experiments described here 
was to use well-characterized viruses and mice that differ in α2 integrin expression to 
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determine whether integrin utilization is required for reovirus pathogenesis and test the 
hypothesis that a viral receptor contributes to reovirus tropism, spread, and disease 
outcome.     
 
Results  
To determine whether α2 integrin contributes to reovirus pathogenesis, neonatal 
wild-type and α2-null mice were infected perorally with reovirus strain T3SA+ (14, 177).  
T3SA+ is a sialic-acid binding strain that is capable of growth in the intestine and spread 
to distant sites of replication (16).  Mice were inoculated perorally with reovirus strain 
T3SA+ at doses ranging from 102 to 108 PFU/ml or PBS as a control.  Inoculum titer was 
confirmed by plaque assay (256).  Mice were monitored daily for 21 days post-infection 
for signs of reovirus disease and weight changes.  Virulence was determined by defining 
the dose at which 50% of the infected mice become moribund (LD50) (207).  The dose of 
T3SA+ that resulted in 50% mortality in the mice was between 105 – 106 PFU/ml for 
both wild-type and α2-null mice (Fig. 1).  These data suggest that α2 integrin expression 
does not influence reovirus virulence in mice.  Both wild-type and α2-null mice 
developed signs of illness including weight loss, ruffled fur, and neurological effects such 
as hind-limb paralysis.   
 
Conclusions 
These data suggest that α2 integrin is not required for reovirus virulence and 
disease.  LD50 analysis is a gross assessment of virulence with fatal illness as an end 
result.  Therefore, it is possible that integrins contribute to reovirus pathogenesis at a  
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Fig. 1.  The T3SA+ LD50 Dose is Equivalent in α2-null and Wild-type Mice.  
Neonatal α2-null and wild-type mice were inoculated PO with T3SA+ at a range of 
doses, 102 – 107 PFU/ml.  Mice were monitored daily for weight changes and signs of 
illness.  Mice that were moribund were euthanized.  Data represent the % mortality of 
infected mice.  The dotted line represents 50%.  Each time point represents at least 
n≥4 mice.  
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tissue-specific level.  Simultaneously, I performed further studies in the laboratory to 
determine whether α2β1 integrin is involved in reovirus infection.  Studies using a larger 
panel of α2-specific antibodies failed to demonstrate a function for α2 integrin in 
reovirus infection (data not shown).  It is possible that MAb AA10 has non-specific 
inhibitory effects on reovirus infection as the antibody is of the IgM isotype (24).  
Additionally, I performed extensive studies using ELISA and GST-precipitation assays to 
test for a direct interaction between the α2 I domain and reovirus.  While there was 
modest binding of reovirus virions to the α2 I domain, binding was not inhibited by 
neutralizing reovirus antibodies or function-blocking α2 antibodies (data not shown), 
suggesting that the interaction was not specific.  Furthermore, a preparation of L cells that 
were processed as a mock viral purification also were capable of modest binding to α2 I 
domain (data not shown), suggesting that a component of the viral purification may 
mediate binding to the α2 I domain, perhaps collagen.  These data do not exclude the 
possibility that α2 integrin is required for reovirus infection.  However, subsequent 
studies revealed that reovirus internalization is mediated by β1 integrin.  Studies using 
mice altered in β1 integrin expression should be performed to determine whether 
integrins contribute to reovirus pathogenesis.   
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Introduction  
 
   During my dissertation research I developed new methods to quantitate reovirus 
internalization and measure transcription as a marker for functional reovirus entry.  The 
methods commonly used to assess reovirus infection are FFU assay and plaque assay.  
These assays are usually processed at 16-24 h or 24-48 h post-infection, respectively.  
However, I wanted to employ assays that would allow me to study viral entry events at 
earlier times.  Studies using inhibitors of viral disassembly suggest that reovirus 
disassembly is complete within 30-45 mins post-adsorption (239), suggesting that 
internalization occurs rapidly after viral adsorption.  Thus, I developed two techniques to 
study reovirus internalization.  The first approach is a microscopy-based assay, which 
was developed with intellectual contributions from Aaron Derdowski and technical 
assistance from Sarah Kopecky-Bromberg.  The second is an RT-PCR-based early 
infectivity assay (EIA), which was developed with intellectual contributions from Pranav 
Danthi and the technical assistance of Wesley Skelton.    
 
Microscopy-Based Internalization Assay 
 A microscopy-based internalization assay was designed to quantify internalization 
of reovirus particles at early-times post adsorption.  This method employs indirect 
immunofluorescence to assess internalization of reovirus particles into cells.  Cells are 
plated onto glass coverslips and incubated overnight.  Then cells are infected with 
reovirus virions and incubated at 4°C for 1h.  Cells are washed with PBS and either fixed 
with 10% formalin or complete medium is added and cells are incubated over a time 
course of reovirus entry (0-45 min).  Cells are fixed in 10% formalin for 20 mins, then 
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washed with PBS, and stored in PBS.  Cells are incubated with 1% TX-100 for 5 mins, 
PBS-BGT for 10 mins, and then incubated with primary antibody, reovirus polyclonal 
antiserum (1:500) diluted in PBS-BGT at room temperature for 1 h.  Cells are washed 
extensively with PBS-BGT, 3 times for 15 min, with rocking.  Cells are then incubated 
with a fluorescently-conjugated secondary antibody (goat-anti-rabbit Alexa 488 or 546 
[Molecular Probes]) in PBS-BGT at room temperature for 1 h, and then washed 
extensively.  Coverslips are mounted onto slides using anti-fade polymount media and 
stored in the dark.  Cells are analyzed by confocal microscopy using an LSM510 
confocal microscope with Meta software.   
 Particle intracellular localization can be determined by obtaining confocal 
micrographs of Z-sections and evaluated using Z-stack analysis and 3D-image 
reconstruction.  Pixel intensity can be measured for an individual cell using Metamorph 
software, providing a quantitative method to assess reovirus internalization.  In the 
absence of Metamorph software, fluorescent particles can be enumerated manually.  
Since this assay does not detect new reovirus protein synthesis as in an FFU assay, it is 
necessary to use a high MOI to detect signal.  I have performed the majority of these 
experiments using 50,000 particles per cell.  This assay allows detection of reovirus 
particles internalized into the cell during very early times post-infection.  However, this is 
not a functional assessment of reovirus infection, and thus should be paired with other 
methods to analyze infectivity.  Examples of this assay can be seen in Chapters II (Fig. 
14) and III (Fig. 17, 18).  
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Early Infectivity Assay (EIA) 
 To study early events in the reovirus life cycle by a method that would allow 
functional assessment of viral infection, I developed an RT-PCR-based protocol to 
quantify viral transcription.  This assay was adapted from methods developed by Leary et 
al. to detect reovirus RNA using RT-PCR (140, 141).  While this assay should be 
adjusted based on individual usage for each cell line, virus strain, and time point, the 
general principle should apply to studies of early events in the reovirus life cycle.   
 HeLa cells (106) are plated in a 60 mm dish and infected with virions or ISVPs of 
reovirus strain T1L at an MOI of 1,000 particles per cell.  Cells are adsorbed with virus at 
4°C for 1 h.  Cells are then washed with PBS and either harvested or complete medium is 
added and cells are incubated at 37°C for 3-4 h.  Cells are harvested by scraping in 1 ml 
of PBS and pelleted in a microfuge at 3,000 x g.  PBS is aspirated and pellets are stored 
at -20 or -70°C until all time points are harvested.  RNA is isolated from cell pellets using 
an RNeasy Mini Kit (Qiagen) and eluted in 30μl.  Extracted RNA (5 μl) is utilized for a 
one-step RT-PCR (Qiagen) with β-actin-specific primers and reovirus λ3-encoding L1-
specific primers.  Resultant RT-PCR products are resolved by agarose gel electrophoresis 
in a 1% agarose gel and stained with ethidium bromide (Fig. 1).  This method measures 
new viral RNA synthesis, as ribavirin, which inhibits viral transcription (206), inhibits 
RNA detected from cells infected with virions (Fig. 1).  Ribavirin does not inhibit RNA 
detected from cells infected with ISVPs (Fig. 1).  The lack of inhibition may be a result 
of the intensity of the amplicons in this experiment.  However, since ISVPs enter cells 
more efficiently than do virions, the concentration of ribavirin used may not be sufficient 
to inhibit transcription by ISVPs.  Additionally, treatment of cells with AC results in  
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Fig. 1.  Reovirus Early Infectivity Assay.  1x106 HeLa cells were untreated or 
pretreated with 40mM AC at 37°C for 1 h.  Cells were infected with virions or ISVPs 
of T1L at 4°C for 1 h, washed, and harvested (0 h) or complete medium with or 
without 200μM ribavirin or AC was added and cells were incubated at 37°C for 4 h.  
Cells were washed, scraped in PBS, and pelleted at 2,000 x g for 5 mins.  PBS was 
aspirated, and RNA was isolated from cells and used as template for RT-PCR using β-
actin- (control) (top) and reovirus L1-specific primers (bottom).  15μl of RT-PCR 
products were subjected to agarose gel electrophoresis and stained with ethidium 
bromide.  T1L and ISVP represent input viral particles prepared as described as 
positive controls.     
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diminished detection of RNA by virions but not by ISVPs (Fig. 1).  However, a slight 
amount of RNA can be detected at 0 h, especially with higher MOIs or when using 
ISVPs, suggesting that this assay is sufficiently sensitive to detect genomic RNA when a 
high MOI is used.  This approach provides a new technique to detect early events in the 
reovirus life cycle.  This assay should be adapted for quantitative PCR.  The RT-PCR 
conditions and primer sequences are listed below.   
RT-PCR conditions:  
Preheat block to 50ºC 
50ºC   30 min 
95ºC   15 min 
94ºC   1 min -----I 
55ºC   1 min     I  35 cycles  
72ºC   1 min -----I 
72ºC   10 min 
4ºC      ∞ 
 
L1 primers 
L1.rv5m: 5’ CTGCATCCATTGTAAATGACGAGTC  3’ 
L1.rv4m: 5’ GCTATGTCATATTTCCATCCGAATTC  3’ 
 
Human B-actin 
B-actin L AGAAAATCTGGCACCACACC 
B-actin R CCATCTCTTGCTCGAAGTCC 
 
Conclusions 
 The microscopy-based internalization assay provides a method to study reovirus 
internalization.  The RT-PCR-based EIA provides a method to study functional reovirus 
entry, as viral transcription is assessed, as early as 3 h post-infection.  These assays 
establish new ways to study early events in reovirus entry and can be adapted for future 
studies.  
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